| For: | Takahashi Y, Fukusato T. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2014; 20(42): 15539-15548 [PMID: 25400438 DOI: 10.3748/wjg.v20.i42.15539] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i42/15539.htm |
| Number | Citing Articles |
| 1 |
Isabel Fuster-Martínez, Vanesa Bernal-Monterde, Guillaume Bidault, José M. Arbonés-Mainar, Antonio Vidal-Puig. Hypoxia in MASLD: a spatial determinant of the pathogenesis. Trends in Molecular Medicine 2026; 32(8) doi: 10.1016/j.molmed.2025.12.008
|
| 2 |
Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato. Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors. Biomedicines 2023; 11(10) doi: 10.3390/biomedicines11102761
|
| 3 |
Noreen Neuwirth, Samuel Kochenburger, Christian Sina. Mikrobiom und metabolische Fettlebererkrankung (MeFLD). Der Diabetologe 2021; 17(4) doi: 10.1007/s11428-021-00725-z
|
| 4 |
Gabriel De la Cruz-Ku, Alba Zevallos, César Ramón Rázuri-Bustamante, Sasank Kalipatnapu, Fortunato S. Príncipe-Meneses, Paola Dongo, Diego Chambergo-Michilot, Gustavo Salinas-Sedo, Bryan Valcarcel. Predictors of Nonalcoholic Steatohepatitis Severity in Obese Patients Undergoing Bariatric Surgery: A Cross-Sectional Study. Bariatric Surgical Practice and Patient Care 2023; 18(4) doi: 10.1089/bari.2022.0043
|
| 5 |
Benjamin Wolfson, Pang‐Kuo Lo, Yuan Yao, Linhao Li, Hongbing Wang, Qun Zhou. Impact of miR‐140 Deficiency on Non‐Alcoholic Fatty Liver Disease. Molecular Nutrition & Food Research 2018; 62(13) doi: 10.1002/mnfr.201800189
|
| 6 |
Kylynda C. Bauer, Paula T. Littlejohn, Victoria Ayala, Anna Creus-Cuadros, B. Brett Finlay. Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective. Gastroenterology 2022; 162(7) doi: 10.1053/j.gastro.2022.01.058
|
| 7 |
Igor Gurevich, Sarah A. Burton, Christie Munn, Makiko Ohshima, Madelyn E. Goedland, Katherine Czysz, Deepika Rajesh. iPSC-derived hepatocytes generated from NASH donors provide a valuable platform for disease modeling and drug discovery. Biology Open 2020; doi: 10.1242/bio.055087
|
| 8 |
Fatima Al-Sharhan, Anthony Dohan, Maxime Barat, Adlane Feddal, Benoit Terris, Stanislas Pol, Vincent Mallet, Philippe Soyer. MRI presentation of hepatocellular carcinoma in non-alcoholic steatohepatitis (NASH). European Journal of Radiology 2019; 119 doi: 10.1016/j.ejrad.2019.108648
|
| 9 |
Vaihere Delaune, Lorenzo A. Orci, Stéphanie Lacotte, Andrea Peloso, Jacques Schrenzel, Vladimir Lazarevic, Christian Toso. Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response. Expert Opinion on Biological Therapy 2018; 18(10) doi: 10.1080/14712598.2018.1518424
|
| 10 |
Athanasia Mitsala, Christos Tsalikidis, Konstantinos Romanidis, Michail Pitiakoudis. Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?. Current Oncology 2022; 29(7) doi: 10.3390/curroncol29070356
|
| 11 |
David Li, Paul A. Janmey, Rebecca G. Wells. Local fat content determines global and local stiffness in livers with simple steatosis. FASEB BioAdvances 2023; 5(6) doi: 10.1096/fba.2022-00134
|
| 12 |
Ashvin Bashyam, Chris J. Frangieh, Siavash Raigani, Jeremy Sogo, Roderick T. Bronson, Korkut Uygun, Heidi Yeh, Dennis A. Ausiello, Michael J. Cima. A portable single-sided magnetic-resonance sensor for the grading of liver steatosis and fibrosis. Nature Biomedical Engineering 2020; 5(3) doi: 10.1038/s41551-020-00638-0
|
| 13 |
Yuxue Zhang, Chang Liu, Weiyi He, Wenhui Li, Wentao Duan, Chaofeng Wu, Hui Jia, Jieying Lan, Zeyu Tong, Qiaohui Du, Haiyan Lin, Zhuowei Gao, Wenxia Zhao, Piao Luo, Lei Gao. Piezo1 as a novel therapeutic target of salvianolic acid B for metabolic dysfunction-associated steatotic liver disease. Phytomedicine 2026; 159 doi: 10.1016/j.phymed.2026.158546
|
| 14 |
Wenqing Mei, Yarong Hao, Huilin Xie, Yingdong Ni, Ruqian Zhao. Hepatic Inflammatory Response to Exogenous LPS Challenge is Exacerbated in Broilers with Fatty Liver Disease. Animals 2020; 10(3) doi: 10.3390/ani10030514
|
| 15 |
Darrell Pilling, Tejas R. Karhadkar, Richard H. Gomer. High-Fat Diet–Induced Adipose Tissue and Liver Inflammation and Steatosis in Mice Are Reduced by Inhibiting Sialidases. The American Journal of Pathology 2021; 191(1) doi: 10.1016/j.ajpath.2020.09.011
|
| 16 |
Daniela S. Rivera, Carolina B. Lindsay, Juan F. Codocedo, Laura E. Carreño, Daniel Cabrera, Marco A. Arrese, Carlos P. Vio, Francisco Bozinovic, Nibaldo C. Inestrosa. Long-Term, Fructose-Induced Metabolic Syndrome-Like Condition Is Associated with Higher Metabolism, Reduced Synaptic Plasticity and Cognitive Impairment in Octodon degus. Molecular Neurobiology 2018; 55(12) doi: 10.1007/s12035-018-0969-0
|
| 17 |
Emrah Doğan, Ferda Bacaksızlar Sarı. Is Fat Deposition of Renal Sinus a Concomitant Finding to Fatty Liver Disease? The First Study Regarding the Relationship Between Kidney and Liver Fat Content with Non-Contrast Computed Tomography. Spartan Medical Research Journal 2022; 7(1) doi: 10.51894/001c.32411
|
| 18 |
Toxicological and nutritional evaluation of plant cell cultures from scurvy grass (Cochlearia danica) and rowan (Sorbus aucuparia). Frontiers in Toxicology 2025; 7 doi: 10.3389/ftox.2025.1655489
|
| 19 |
Asrın NALBANT, Bayram Ufuk ŞAKUL, Ferruh YÜCEL. Investigation of Changes in Liver Microanatomy in the Steatosis Model Created by Permanent Canula in Rats. Clinical and Experimental Health Sciences 2022; 12(3) doi: 10.33808/clinexphealthsci.948391
|
| 20 |
Ana Sandoval‐Rodriguez, Hugo Christian Monroy‐Ramirez, Alejandra Meza‐Rios, Jesus Garcia‐Bañuelos, Jose Vera‐Cruz, Jorge Gutiérrez‐Cuevas, Jorge Silva‐Gomez, Bart Staels, Jose Dominguez‐Rosales, Marina Galicia‐Moreno, Monica Vazquez‐Del Mercado, Jose Navarro‐Partida, Arturo Santos‐Garcia, Juan Armendariz‐Borunda. Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK. Hepatology Communications 2020; 4(3) doi: 10.1002/hep4.1474
|
| 21 |
Mi Hye Kim, Sun-Ji Park, Jung-Hak Kim, Jung Bae Seong, Kyung-Min Kim, Hyun Ae Woo, Dong-Seok Lee. Peroxiredoxin 5 regulates adipogenesis-attenuating oxidative stress in obese mouse models induced by a high-fat diet. Free Radical Biology and Medicine 2018; 123 doi: 10.1016/j.freeradbiomed.2018.05.061
|
| 22 |
Angeliki Papachristodoulou, Dimitrios Kavvadas, Athanasios Karamitsos, Theodora Papamitsou, Maria Chatzidimitriou, Antonia Sioga. Diagnosis and Staging of Pediatric Non-Alcoholic Fatty Liver Disease: Is Classical Ultrasound the Answer?. Pediatric Reports 2021; 13(2) doi: 10.3390/pediatric13020039
|
| 23 |
Verena Habermaass, Yuki Takami, Takeshi Izawa, Francesca Abramo, Corrado Biolatti, Veronica Marchetti. Lipid Dysmetabolism in Canine Chronic Liver Disease: Relationship Between Clinical, Histological and Immunohistochemical Features. Veterinary Sciences 2025; 12(3) doi: 10.3390/vetsci12030220
|
| 24 |
Yuichiro Eguchi, Gabriel Wong, Omar Akhtar, Yoshio Sumida. Non‐invasive diagnosis of non‐alcoholic steatohepatitis and advanced fibrosis in Japan: A targeted literature review. Hepatology Research 2020; 50(6) doi: 10.1111/hepr.13502
|
| 25 |
Kavita Goyal, Muhammad Afzal, Ashok Kumar Bishoyi, R. Roopashree, Suman Saini, R. S. K. Sharma, Piyus Kumar Pathak, Ashish Singh Chauhan, Surendar Aravindhan, Mohd Imran, Abida Abida Abida. Ubiquitin-specific proteases in hepatitis: bridging molecular mechanisms and therapeutic potential. Egyptian Liver Journal 2025; 15(1) doi: 10.1186/s43066-025-00434-y
|
| 26 |
Ivana Masci, Carola Bozal, Christian Lezón, Maximiliano Martin, Fernando Brites, Julián Bonetto, Laura Alvarez, Melisa Kurtz, Deborah Tasat. Exposure to airborne particulate matter and undernutrition in young rats: An in-depth histopathological and biochemical study on lung and excretory organs. Food and Chemical Toxicology 2025; 197 doi: 10.1016/j.fct.2025.115246
|
| 27 |
Reda Albadawy, Sara H. A. Agwa, Eman Khairy, Maha Saad, Naglaa El Touchy, Mohamed Othman, Marwa Matboli. Clinical Significance of HSPD1/MMP14/ITGB1/miR-6881-5P/Lnc-SPARCL1-1:2 RNA Panel in NAFLD/NASH Diagnosis: Egyptian Pilot Study. Biomedicines 2021; 9(9) doi: 10.3390/biomedicines9091248
|
| 28 |
Yoshio Shimizu, Takafumi Tamura, Akira Kemmochi, Yohei Owada, Yusuke Ozawa, Katsuji Hisakura, Takashi Matsuzaka, Hitoshi Shimano, Noriyuki Nakano, Shingo Sakashita, Tatsuya Oda, Nobuhiro Ohkohchi. Oxidative stress and Liver X Receptor agonist induce hepatocellular carcinoma in Non‐alcoholic steatohepatitis model. Journal of Gastroenterology and Hepatology 2021; 36(3) doi: 10.1111/jgh.15239
|
| 29 |
Everton Cazzo, José Carlos Pareja, Elinton Adami Chaim. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review. Sao Paulo Medical Journal 2017; 135(3) doi: 10.1590/1516-3180.2016.0306311216
|
| 30 |
Muhammad Umair Latif, Geske Elisabeth Schmidt, Sercan Mercan, Raza Rahman, Christine Silvia Gibhardt, Ioana Stejerean-Todoran, Kristina Reutlinger, Elisabeth Hessmann, Shiv K Singh, Abdul Moeed, Abdul Rehman, Umer Javed Butt, Hanibal Bohnenberger, Philipp Stroebel, Sebastian Christopher Bremer, Albrecht Neesse, Ivan Bogeski, Volker Ellenrieder. NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression. Gut 2022; 71(12) doi: 10.1136/gutjnl-2021-325013
|
| 31 |
Mahitab Mohamed Nageeb, Monira Ismaeil Khatab, Ahmed Ahmed Abdel-sameea, Noha Abbas Teleb. Adelmidrol protects against non-alcoholic steatohepatitis in mice. Naunyn-Schmiedeberg's Archives of Pharmacology 2020; 393(5) doi: 10.1007/s00210-019-01785-1
|
| 32 |
K. C. Bauer, K. E. Huus, E. M. Brown, T. Bozorgmehr, C. Petersen, M. S. Cirstea, S. E. Woodward, J. McCoy, J. Hun, R. Pamplona, V. Ayala, B. B. Finlay, Chaysavanh Manichanh. Dietary Intervention Reverses Fatty Liver and Altered Gut Microbiota during Early-Life Undernutrition. mSystems 2020; 5(5) doi: 10.1128/mSystems.00499-20
|
| 33 |
Kibo Nam, Mehnoosh Torkzaban, Dina Halegoua-DeMarzio, Corinne E Wessner, Andrej Lyshchik. Improving diagnostic accuracy of ultrasound texture features in detecting and quantifying hepatic steatosis using various beamforming sound speeds. Physics in Medicine & Biology 2023; 68(4) doi: 10.1088/1361-6560/acb635
|
| 34 |
Shuyun Wei, Shuiping Zhang, Jiahui Luo, Wenxin Yu, Xing Zeng, Lunli Lan, Cuiping Yu, Yu Zeng, Yi Feng. Liupao Tea Ameliorates High‐Fat Diet‐Induced Non‐Alcoholic Fatty Liver Disease via Arginine Metabolism: Insights From Metabolomics and Network Pharmacology. Biomedical Chromatography 2025; 39(9) doi: 10.1002/bmc.70166
|
| 35 |
Agostina M. Onorato, Lucía Lameroli Mauriz, Juan Bayo, Esteban Fiore, María José Cantero, Barbara Bueloni, Mariana García, Cecilia Lagües, Pedro Martínez-Duartez, Gabriel Menaldi, Nicolas Paleari, Catalina Atorrasagasti, Guillermo D. Mazzolini. Hepatic SPARC Expression Is Associated with Inflammasome Activation during the Progression of Non-Alcoholic Fatty Liver Disease in Both Mice and Morbidly Obese Patients. International Journal of Molecular Sciences 2023; 24(19) doi: 10.3390/ijms241914843
|
| 36 |
Evgenii Gusev, Alexey Sarapultsev, Yulia Zhuravleva. Insulin Resistance and Inflammation. International Journal of Molecular Sciences 2026; 27(3) doi: 10.3390/ijms27031237
|
| 37 |
Martina Chiurazzi, Nunzia Cacciapuoti, Mariastella Di Lauro, Gilda Nasti, Margherita Ceparano, Elisabetta Salomone, Bruna Guida, Maria Serena Lonardo. The Synergic Effect of a Nutraceutical Supplementation Associated to a Mediterranean Hypocaloric Diet in a Population of Overweight/Obese Adults with NAFLD. Nutrients 2022; 14(22) doi: 10.3390/nu14224750
|
| 38 |
Hadith Tangestani, Ali Jamshidi, Akram Farhadi, Hamid Ghalandari, Pardis Dehghani, Nika Moghaddas, Zahra Safaei, Hadi Emamat. The effects of pomegranate (Punica granatum) on nonalcoholic fatty liver disease: A systematic review of in vivo interventional studies. Phytotherapy Research 2024; 38(8) doi: 10.1002/ptr.8272
|
| 39 |
Ekin Guney, Ana Paula Arruda, Günes Parlakgul, Erika Cagampan, Nina Min, Grace Yankun Lee, Lily Greene, Eva Tsaousidou, Karen Inouye, Myoung Sook Han, Roger J. Davis, Gökhan S. Hotamisligil.
Aberrant Ca
2+
signaling by IP
3
Rs in adipocytes links inflammation to metabolic dysregulation in obesity
. Science Signaling 2021; 14(713) doi: 10.1126/scisignal.abf2059
|
| 40 |
Rallia-Iliana Velliou, Eirini Giannousi, Christiana Ralliou, Eva Kassi, Antonios Chatzigeorgiou. Ex Vivo Tools and Models in MASLD Research. Cells 2024; 13(22) doi: 10.3390/cells13221827
|
| 41 |
D Santhosh Reddy, R Bharath, P Rajalakshmi. Classification of Nonalcoholic Fatty Liver Texture Using Convolution Neural Networks. 2018 IEEE 20th International Conference on e-Health Networking, Applications and Services (Healthcom) 2018; doi: 10.1109/HealthCom.2018.8531193
|
| 42 |
Fatemeh Esmaeilzadeh, Farshid Kafilzadeh, Noosha Zia Jahromi, Leila Kohan, Samaneh Zolghadri. Regulatory role of circ-UBR5 in NASH-HCC pathogenesis via interaction with disease-associated miRNA. Gene Reports 2026; 44 doi: 10.1016/j.genrep.2026.102560
|
| 43 |
Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato. Artificial intelligence and deep learning: New tools for histopathological diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Computational and Structural Biotechnology Journal 2023; 21 doi: 10.1016/j.csbj.2023.03.048
|
| 44 |
V.S. Trifanov, V.V. Kopylov, N.A. Grishin, N.N. Volchenko, M.E. Malushkova, A.A. Troitsky, R.I. Moshurov, S.I. Poluektov, M.V. Kosogolov. Hepatocellular carcinoma associated with nonalcoholic fatty liver disease. P.A. Herzen Journal of Oncology 2024; 13(6) doi: 10.17116/onkolog20241306157
|
| 45 |
Ma. Enrica Angela Ching, Myriam P. Hoyeck, Lahari Basu, Rayanna Merhi, Emilia Poleo-Giordani, Erin van Zyl, Angela M. Crawley, Jennifer E. Bruin. CYP1A1/1A2 enzymes mediate glucose homeostasis and insulin secretion in mice in a sex-specific manner. American Journal of Physiology-Endocrinology and Metabolism 2025; 328(6) doi: 10.1152/ajpendo.00284.2024
|
| 46 |
Lara Mari, Stefano Lazzer, Alessandro Gatti, Mattia D’Alleva, Simone Zaccaron, Jacopo Stafuzza, Enrico Rejc, Matteo Vandoni, Adele Bondesan, Diana Caroli, Francesca Frigerio, Laura Abbruzzese, Enrica Ventura, Alessandro Sartorio. Visceral Adiposity, Anthropometric and Liver Function Indexes for Identifying Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) in Adolescents with Obesity: Which Performs Better?. Journal of Clinical Medicine 2025; 14(6) doi: 10.3390/jcm14062085
|
| 47 |
Mirela Marinela Florescu, Dan Ionuț Gheonea. Essentials of Non-Alcoholic Fatty Liver Disease. 2023; doi: 10.1007/978-3-031-33548-8_8
|
| 48 |
Chun‐Hsien Chiang, Pu‐Sheng Hsu, Shau‐Ping Lin, Ching‐Yi Chen. High-fat diet restriction to adult male mice maintains normal body weight but leads to liver impairment by disrupting mitochondrial oxidative phosphorylation. The Journal of Nutritional Biochemistry 2025; 143 doi: 10.1016/j.jnutbio.2025.109941
|
| 49 |
Junhui Yu, Ningning Shao, Jianming Yang, Long Yang, Kaiwen Hong, Yuzhu Chen, Xiaoming Zhao, Hongzhi Yu, Tao Zhang, Jinrui Dong. Ultrafine garlic powder alleviates non-alcoholic steatohepatitis by inhibiting hepatocyte ferroptosis and modulating ERK-dependent oxidative stress. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1711917
|
| 50 |
David Sooik Kim, Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim. Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir. Clinical and Molecular Hepatology 2019; 25(3) doi: 10.3350/cmh.2018.0054
|
| 51 |
William Ka Fai Tse, Jing Woei Li, Anna Chung Kwan Tse, Ting Fung Chan, Jeff Cheuk Hin Ho, Rudolf Shiu Sun Wu, Chris Kong Chu Wong, Keng Po Lai. Fatty liver disease induced by perfluorooctane sulfonate: Novel insight from transcriptome analysis. Chemosphere 2016; 159 doi: 10.1016/j.chemosphere.2016.05.060
|
| 52 |
Quiana C. Wilkerson-Vidal, Madushika M. Wimalarathne, Emily C. Hunt, Luis Mercado, Moses Adaji David, Christopher R. Apperson, Alan Smiley, Sharifa Tahirah Love-Rutledge, Bernhard W. G. Vogler. Male LEW.1WR1 Rats Develop Metabolic Dysfunction, Steatohepatitis, and Liver Damage. Endocrines 2024; 5(2) doi: 10.3390/endocrines5020012
|
| 53 |
Tharani Senavirathna, Armaghan Shafaei, Ricky R. Lareu, Lois Balmer. Ellagic Acid Reduces Inulin's Adverse Effects: A Combined Approach to Enhance Therapeutic Potential in Nonalcoholic Steatohepatitis. Molecular Nutrition & Food Research 2026; 70(7) doi: 10.1002/mnfr.70456
|
| 54 |
Yoshihisa Takahashi, Toshio Fukusato. Animal Models for the Study of Human Disease. 2017; doi: 10.1016/B978-0-12-809468-6.00013-9
|
| 55 |
Jia Xu, Hong Zhang, Hong Chen, Xiaoxue Zhu, Haiyan Jia, Zhongnan Xu, Dandan Huo, Hong Zhang, Cuiyun Li, Yanhua Ding. Safety, tolerability, pharmacokinetics and pharmacodynamics of a novel farnesoid X receptor (FXR) agonist-TQA3526 in healthy Chinese volunteers: a double-blind, randomized, placebo-controlled, dose-escalation, food effect phase I study. Annals of Medicine 2023; 55(2) doi: 10.1080/07853890.2023.2264850
|
| 56 |
Lindsey Kennedy, Laura Hargrove, Jennifer Demieville, Jennifer M. Bailey, Wasim Dar, Kishore Polireddy, Qingzheng Chen, Moises I. Nevah Rubin, Amelia Sybenga, Sharon DeMorrow, Fanyin Meng, Lindsey Stockton, Gianfranco Alpini, Heather Francis. Knockout of l-Histidine Decarboxylase Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling. The American Journal of Pathology 2018; 188(3) doi: 10.1016/j.ajpath.2017.11.016
|
| 57 |
Shaiju S. Nazeer, T.P. Sreedevi, Ramapurath S. Jayasree. Autofluorescence spectroscopy and multivariate analysis for predicting the induced damages to other organs due to liver fibrosis. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2021; 257 doi: 10.1016/j.saa.2021.119741
|
| 58 |
Mayuko Ichimura‐Shimizu, Masami Kojima, Shingo Suzuki, Misaki Miyata, Yui Osaki, Konomi Matsui, Toshiyuki Mizui, Koichi Tsuneyama. Brain‐derived neurotrophic factor knock‐out mice develop non‐alcoholic steatohepatitis. The Journal of Pathology 2023; 261(4) doi: 10.1002/path.6204
|
| 59 |
Linda Vanessa Márquez-Quiroga, Eduardo E. Vargas-Pozada, Irina Cardoso-Lezama, Erika Ramos-Tovar, Verónica Rocío Vásquez-Garzón, Carolina Piña-Vázquez, Saúl Villa-Treviño, Jaime Arellanes-Robledo, Pablo Muriel. Chronological activation of the NLRP3 inflammasome/pyroptosis pathway in the progression from metabolic dysfunction-associated fatty liver disease to hepatocellular carcinoma. Toxicology Mechanisms and Methods 2025; 35(8) doi: 10.1080/15376516.2025.2524749
|
| 60 |
Tian Shen, Bilin Xu, Tao Lei, Lin Chen, Cuiping Zhang, Zhenhua Ni. Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKα pathway. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6554
|
| 61 |
Çağrı Damar, Emregül Işık, Şükrü Güngör. Relationship between Quantitative Sonographic Measurements and Serum Biochemical Parameters in Childhood Obesity. Pediatric Gastroenterology, Hepatology & Nutrition 2021; 24(5) doi: 10.5223/pghn.2021.24.5.470
|
| 62 |
Andrea Carloni, Michaela Paninarova, Damiano Cavina, Mariarita Romanucci, Leonardo Della Salda, Simone Teodori, Massimo Vignoli. Negative hepatic computed tomographic attenuation pattern in a dog with vacuolar hepatopathy and hepatic fat accumulation secondary to cushing's syndrome. Veterinary Radiology & Ultrasound 2019; 60(5) doi: 10.1111/vru.12568
|
| 63 |
Grigorios Papadopoulos, Eirini Giannousi, Aikaterini P. Avdi, Rallia-Iliana Velliou, Polyxeni Nikolakopoulou, Antonios Chatzigeorgiou. Τ cell-mediated adaptive immunity in the transition from metabolic dysfunction-associated steatohepatitis to hepatocellular carcinoma. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1343806
|
| 64 |
Rocío Aller, José Luis Calleja, Javier Crespo, Manuel Romero-Gómez, Juan Turnes, Omar J. Benmarzouk-Hidalgo, Rafael Subirán, Alicia Gil. Advanced fibrosis associated with non-alcoholic steatohepatitis (NASH) in Spain: Results of a Delphi study. Gastroenterología y Hepatología (English Edition) 2024; 47(4) doi: 10.1016/j.gastre.2023.06.003
|
| 65 |
C.A. Lamas, S.A. Lenquiste, A.M. Baseggio, L. Cuquetto-Leite, L.A. Kido, A.C. Aguiar, M.N. Erbelin, C.B. Collares-Buzato, M.R. Maróstica, V.H.A. Cagnon. Jaboticaba extract prevents prediabetes and liver steatosis in high-fat-fed aging mice. Journal of Functional Foods 2018; 47 doi: 10.1016/j.jff.2018.06.005
|
| 66 |
Xianwen Chen, Junnan Shi, Yunfeng Lai, Yan Xue, Carolina Oi Lam Ung, Hao Hu. Systematic analysis of randomised controlled trials of Chinese herb medicine for non-alcoholic steatohepatitis (NASH): implications for future drug development and trial design. Chinese Medicine 2023; 18(1) doi: 10.1186/s13020-023-00761-5
|
| 67 |
Nadine Daou, Andreu Viader, Murat Cokol, Arianna Nitzel, Manu V. Chakravarthy, Raffi Afeyan, Tony Tramontin, Svetlana Marukian, Michael J. Hamill. A novel, multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation, and fibrosis in nonalcoholic steatohepatitis-relevant primary human cell models. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-88913-1
|
| 68 |
|
| 69 |
Zizhen Yang, Fengjuan Zhang, Hui Li, Bei Liu, Peng Liu, Zhinan Wu, Yichen Li, Jiahao Miao, Xiaofang Li, Hewei Liang, Yiyi Zhong, Liang Xiao, Yuanqiang Zou, Ningning He, Shangyong Li. Gut Commensal Phocaeicola vulgatus AF107-22 Alleviates Obesity-Induced Metabolic Syndrome via Promoting Gut Microbiota-Derived Spermidine Synthesis. Journal of Agricultural and Food Chemistry 2026; 74(7) doi: 10.1021/acs.jafc.5c14443
|
| 70 |
Lida Chatzi, David V Conti, Rob McConnell, Andrea A Baccarelli, Stavra A Xanthakos, Rohit Kohli, Stephanie Sisley, Todd Jenkins, Thomas H Inge, Justin R Ryder, Michele A La Merrill, Damaskini Valvi, Douglas I Walker, Sandrah P Eckel, Hong-Xu Wang, Max T Aung, Yin-Qi Zhao, Jing-Xuan He, Hao-Tian Wu, Jesse A Goodrich, Nikos Stratakis, Brittney O Baumert, Yi-Jie Li. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity. World Journal of Gastroenterology 2024; 30(4): 332-345 doi: 10.3748/wjg.v30.i4.332
Abstract(799) |
Core Tip(1029) |
Full Article(HTML)(5222)
|
Full Article (PDF)-1390K(310)
|
Full Article with Cover (PDF)-1817K(360)
|
Full Article (Word)-765K(26)
|
Full Article (XML)-191K(155)
|
Audio-1282K(37)
|
Peer-Review Report-233K(169)
|
Answering Reviewers-203K(153)
|
Supplementary Material-59K(183)
|
Times Cited (20)
|
Total Visits (7156)
|
Open
|
| 71 |
Shuqi Wei, Diwen Shou, Siyuan Huang, Yingsi Wang, Quanzhen Liu, Jinfa Liu, Xiaoyu Lv, Yuyi Zeng, Liting Wei, Han Lin, Jiechuan Chen, Yangxiao Chen, Haoyu Zhong, Yanqing Zhou, Wen Ma, Li Wang, Guojun Qian, Jing Guo, Donglin Sun. Nonalcoholic Fatty Liver Disease Exacerbates the Advancement of Renal Fibrosis by Modulating Renal CCR2+PIRB+ Macrophages Through the ANGPTL8/PIRB/ALOX5AP Axis. Advanced Science 2025; 12(46) doi: 10.1002/advs.202509351
|
| 72 |
Hyung-Ran Kim, Eun-Jeong Choi, Jeong-Hae Kie, Joo-Ho Lee, Ju-Young Seoh. Deficiency of glutathione peroxidase-1 and catalase attenuated diet-induced obesity and associated metabolic disorders. Acta Diabetologica 2020; 57(2) doi: 10.1007/s00592-019-01388-5
|
| 73 |
Li-Wei Chen, Cheng-Hung Chien, Sheng-Fong Kuo, Chia-Ying Yu, Chih-Lang Lin, Rong-Nan Chien. Low vitamin D level was associated with metabolic syndrome and high leptin level in subjects with nonalcoholic fatty liver disease: a community-based study. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1040-y
|
| 74 |
Melissa Yepmo, Jean-Baptiste Potier, Michel Pinget, Anastasia Grabarz, Karim Bouzakri, Aurore Dumond Bourie. Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1035159
|
| 75 |
Golnaz Ranjbar, Dimitri P. Mikhailidis, Amirhossein Sahebkar. Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!. Metabolism 2019; 101 doi: 10.1016/j.metabol.2019.154001
|
| 76 |
I. Rodriguez-Ramiro, D. Vauzour, A. M. Minihane. Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms. Proceedings of the Nutrition Society 2016; 75(1) doi: 10.1017/S0029665115004218
|
| 77 |
A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE. PLOS ONE 2019; 14(5) doi: 10.1371/journal.pone.0216736
|
| 78 |
Darrell Pilling, Tejas R. Karhadkar, Richard H. Gomer, Qinghua Sun. A CD209 ligand and a sialidase inhibitor differentially modulate adipose tissue and liver macrophage populations and steatosis in mice on the Methionine and Choline-Deficient (MCD) diet. PLOS ONE 2020; 15(12) doi: 10.1371/journal.pone.0244762
|
| 79 |
Limei Li, Yan Song, Yongquan Shi, Liangliang Sun. Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges. The Journal of Clinical Endocrinology & Metabolism 2023; 108(7) doi: 10.1210/clinem/dgad072
|
| 80 |
Gashaw Hassen, Abhishek Singh, Gizeshwork Belete, Nidhi Jain, Ivonne De la Hoz, Genesis P Camacho-Leon, Nitsuh K Dargie, Keila G Carrera, Tadesse Alemu, Sharan Jhaveri, Nebiyou Solomon. Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease. Cureus 2022; doi: 10.7759/cureus.25495
|
| 81 |
Najla A. Lakkis, Nour M. Mokalled, Mona H. Osman, Umayya M. Musharrafieh, Mohammad Eljammal. Liver Cancer and Risk Factors in the MENA Region: Epidemiology and Temporal Trends Based on the 2019 Global Burden of Disease Data. Cancer Control 2024; 31 doi: 10.1177/10732748241297346
|
| 82 |
Yong‐ho Lee, Seung Up Kim, Kijun Song, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Kwang‐Hyub Han. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008‐2011). Hepatology 2016; 63(3) doi: 10.1002/hep.28376
|
| 83 |
Itzayana Rodríguez‐Antonio, Guillermo N. López‐Sánchez, Misael Uribe, Norberto C. Chávez‐Tapia, Natalia Nuño‐Lámbarri. Role of the inflammasome, gasdermin D, and pyroptosis in non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2021; 36(10) doi: 10.1111/jgh.15561
|
| 84 |
Margaret Spinosa, She-Yan Wong. Screening for Non-alcoholic Fatty Liver Disease in Current Practice. Current Hepatology Reports 2021; 20(4) doi: 10.1007/s11901-021-00577-7
|
| 85 |
Mike F. Renne, Hanaa Hariri. Lipid Droplet-Organelle Contact Sites as Hubs for Fatty Acid Metabolism, Trafficking, and Metabolic Channeling. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.726261
|
| 86 |
Chen Shen, Jin Hong Chen, Ha Ram Oh, Ji Hyun Park. Transcription factor SOX2 contributes to nonalcoholic fatty liver disease development by regulating the expression of the fatty acid transporter CD36. FEBS Letters 2021; 595(19) doi: 10.1002/1873-3468.14193
|
| 87 |
Evangelia E. Tsakiridis, Elham Ahmadi, Jaya Gautam, Yi Ran Hannah She, Russta Fayyazi, James S.V. Lally, Simon Wang, Fiorella Di Pastena, Celina M. Valvano, Daniel Del Rosso, Olga-Demetra Biziotis, Brandon Meyers, Paola Muti, Theodoros Tsakiridis, Gregory R. Steinberg. Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinoma. JHEP Reports 2025; 7(5) doi: 10.1016/j.jhepr.2025.101354
|
| 88 |
Khaled Alkhuder. Raman scattering-based optical sensing of chronic liver diseases. Photodiagnosis and Photodynamic Therapy 2023; 42 doi: 10.1016/j.pdpdt.2023.103505
|
| 89 |
Jaime Moreno, Lise Lotte Gluud, Elisabeth D. Galsgaard, Henning Hvid, Gianluca Mazzoni, Vivek Das, Xianmin Zhu. Identification of ligand and receptor interactions in CKD and MASH through the integration of single cell and spatial transcriptomics. PLOS ONE 2024; 19(5) doi: 10.1371/journal.pone.0302853
|
| 90 |
Mahboobe Hosseinikia, Farhad Oubari, Roghaye Hosseinkia, Zibaneh Tabeshfar, Mohammad Gharib Salehi, Zeinab Mousavian, Mehrnaz Abbasi, Mehnoosh Samadi, Yahya Pasdar. Quercetin supplementation in non-alcoholic fatty liver disease. Nutrition & Food Science 2020; 50(6) doi: 10.1108/NFS-10-2019-0321
|
| 91 |
Ipshita Jain, Rajendra Nath, Madhu Kumar, Rishi Pal, Rakesh Dixit. Comparative Efficacy of Pioglitazone, Saroglitazar, and Silymarin on Biochemical and Histopathological Hepatic Outcomes in a Wistar Rat Model of Non-alcoholic Fatty Liver Disease and Their Correlation With Insulin Sensitivity. Cureus 2026; doi: 10.7759/cureus.103631
|
| 92 |
Zareen Zohara, Ademiniyi Adelekun, Kofi D Seffah, Korlos Salib, Lana Dardari, Maher Taha, Purva Dahat, Stacy Toriola, Travis Satnarine, Ana P Arcia Franchini. The Prospect of Non-Alcoholic Fatty Liver Disease in Adult Patients with Metabolic Syndrome: A Systematic Review. Cureus 2023; doi: 10.7759/cureus.41959
|
| 93 |
Xinying Zhao, Xiangrong Zhou, Keying Li, Qiuchen Wu, Yuqin Sha, Zhuoyi Xie, Ping Zeng, Zhipeng Qi, Qiao Niu, Wei Li, Weiyi Song. Sub-chronic exposure to lanthanum chloride induces hepatic steatosis via AMPK-dependent lipophagic defects in male zebrafish. Ecotoxicology and Environmental Safety 2026; 322 doi: 10.1016/j.ecoenv.2026.120526
|
| 94 |
Ernesto López-Pascual, Ivan Rienda, Judith Perez-Rojas, Anna Rapisarda, Guillem Garcia-Llorens, Ramiro Jover, José V. Castell. Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways. International Journal of Molecular Sciences 2024; 25(10) doi: 10.3390/ijms25105203
|
| 95 |
Rodrigo Bremer Nones, Cláudia Pontes Ivantes, Maria Lucia Alves Pedroso. Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?. Archives of Endocrinology and Metabolism 2017; 61(3) doi: 10.1590/2359-3997000000233
|
| 96 |
Ignacio Gabriel Scanarotti, Juliana Sain, Ana Fabro, Claudio Adrián Bernal. Virgin flaxseed oil supplemented or not with tocopherols and phytosterols prevents liver steatosis induced by high‐fat diets in male Wistar rats. European Journal of Lipid Science and Technology 2024; 126(5) doi: 10.1002/ejlt.202300203
|
| 97 |
Zhe Zhang, Xiaomin Zheng, Chuyu Dong, Pengru Li, Yi Lin, Zhenzhu Sun, Wenjing Li, Xiaoxiao Liu, Jing Li, Shan Li, Bing Gu, Lei Zhang. Discovery of Non-Carboxylic Steroidal FXR Agonist as a Promising Preclinical Candidate for Metabolic Dysfunction-Associated Steatohepatitis. Journal of Medicinal Chemistry 2026; 69(10) doi: 10.1021/acs.jmedchem.5c03220
|
| 98 |
Marta B. Afonso, Rui E. Castro, Cecília M. P. Rodrigues. Processes exacerbating apoptosis in non-alcoholic steatohepatitis. Clinical Science 2019; 133(22) doi: 10.1042/CS20190068
|
| 99 |
Jieun Moon, Jehwi Jeon, Eunji Kong, Sujung Hong, Jingu Lee, Eun Kyung Lee, Pilhan Kim. Intravital two-photon imaging and quantification of hepatic steatosis and fibrosis in a live small animal model. Biomedical Optics Express 2021; 12(12) doi: 10.1364/BOE.442608
|
| 100 |
Nana Makiuchi, Shun Takano, Yuki Tada, Kaichi Kasai, Naoya Igarashi, Koudai Kani, Miyuna Kato, Kana Goto, Yudai Matsuura, Mayuko Ichimura-Shimizu, Yukihiro Furusawa, Koichi Tsuneyama, Yoshinori Nagai. Dynamics of Liver Macrophage Subsets in a Novel Mouse Model of Non-Alcoholic Steatohepatitis Using C57BL/6 Mice. Biomedicines 2023; 11(10) doi: 10.3390/biomedicines11102659
|
| 101 |
Involvement of liver kinase B1 in the ameliorative action of epigallocatechin-3-gallate against MAFLD progression in mice. Pharmacia 2025; 72 doi: 10.3897/pharmacia.72.e159024
|
| 102 |
Purbita Bandopadhyay, Dipyaman Ganguly. Human Microbiome in Health and Disease - Part A. Progress in Molecular Biology and Translational Science 2022; 191 doi: 10.1016/bs.pmbts.2022.06.031
|
| 103 |
Zhi Xin Tan, Bryan Mehta, Kieran Kusel, James Seow, Marilyn Zelesco, Steven Abbott, Rebecca Simons, Glenn Boardman, Christopher J. Welman, Oyekoya T. Ayonrinde. Hepatic steatosis: Qualitative and quantitative sonographic assessment in comparison to histology. Australasian Journal of Ultrasound in Medicine 2024; 27(3) doi: 10.1002/ajum.12381
|
| 104 |
Maria Teresa Koenen, Elisa Fabiana Brandt, Dawid Marcin Kaczor, Tim Caspers, Alexandra Catharina Anna Heinzmann, Petra Fischer, Daniel Heinrichs, Theresa Hildegard Wirtz, Christian Trautwein, Rory R Koenen, Marie-Luise Berres. Extracellular Vesicles from Steatotic Hepatocytes Provoke Pro-Fibrotic Responses in Cultured Stellate Cells. Biomolecules 2022; 12(5) doi: 10.3390/biom12050698
|
| 105 |
Inasa Nabila, Maria Selvester Thadeus, Ryan Herardi. Hepatoprotective Effect of Parijoto Fruit Extract (Medinilla speciosa Blume) on Male Mice Fed with High-Fat Diet . Jurnal Gizi dan Pangan 2023; 18(1) doi: 10.25182/jgp.2023.18.1.21-30
|
| 106 |
Janet M. Wojcicki, Ryan M. Gill, Laura Wilson, Jue Lin, Philip Rosenthal. Shorter leukocyte telomere length protects against NAFLD progression in children. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-31149-y
|
| 107 |
Da Hyun Lee, Dai Hoon Han, Ki Taek Nam, Jeong Su Park, Soo Hyun Kim, Milim Lee, Gyuri Kim, Byung Soh Min, Bong-Soo Cha, Yu Seol Lee, Su Haeng Sung, Haengdueng Jeong, Hye Won Ji, Moon Joo Lee, Jae Sung Lee, Hui-Young Lee, Yoomi Chun, Joungmok Kim, Masaaki Komatsu, Yong-ho Lee, Soo Han Bae. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. Free Radical Biology and Medicine 2016; 99 doi: 10.1016/j.freeradbiomed.2016.09.009
|
| 108 |
Nikolaus Bresgen, Melanie Kovacs, Angelika Lahnsteiner, Thomas Klaus Felder, Mark Rinnerthaler. The Janus-Faced Role of Lipid Droplets in Aging: Insights from the Cellular Perspective. Biomolecules 2023; 13(6) doi: 10.3390/biom13060912
|
| 109 |
Haoran Liu, Suhong Wu, Hyunho Lee, Gherardo Baudo, Matteo Massaro, Aijun Zhang, Dale J. Hamilton, Elvin Blanco. Polymer‐Functionalized Mitochondrial Transplantation to Plaque Macrophages as a Therapeutic Strategy Targeting Atherosclerosis. Advanced Therapeutics 2022; 5(5) doi: 10.1002/adtp.202100232
|
| 110 |
Raquel Carvalho-Gontijo, Cuijuan Han, Lei Zhang, Vivian Zhang, Mojgan Hosseini, Kristin Mekeel, Bernd Schnabl, Rohit Loomba, Michael Karin, David A. Brenner, Tatiana Kisseleva. Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD. Seminars in Liver Disease 2022; 42(03) doi: 10.1055/s-0042-1755316
|
| 111 |
Oscar René Zambrano-Vásquez, Fernando Cortes-Camacho, Juan Carlos Cabrera-Angeles, Ana Lilia Hernández-Alba, Fernando Enrique García-Arroyo, Jorge Ismael Castañeda-Sánchez, Elena Aréchaga-Ocampo, Omar Emiliano Aparicio-Trejo, Leonardo Del Valle-Mondragón, Constanza Estefanía Martínez-Olivares, Rogelio Hernández-Pando, Laura Gabriela Sánchez-Lozada, Horacio Osorio-Alonso. The Combination Empagliflozin/Metformin Attenuates the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease in a Diet-Induced Experimental Rat Model. International Journal of Molecular Sciences 2025; 26(18) doi: 10.3390/ijms26189010
|
| 112 |
Tsung-Yuan Yang, Meng-Hsun Yu, Yi-Liang Wu, Ching-Chun Hong, Chin-Shuh Chen, Kuei-Chuan Chan, Chau-Jong Wang. Mulberry Leaf (Morus alba L.) Extracts and Its Chlorogenic Acid Isomer Component Improve Glucolipotoxicity-Induced Hepatic Lipid Accumulation via Downregulating miR-34a and Decreased Inflammation. Nutrients 2022; 14(22) doi: 10.3390/nu14224808
|
| 113 |
Rocío Aller, José Luis Calleja, Javier Crespo, Manuel Romero-Gómez, Juan Turnes, Omar J. Benmarzouk-Hidalgo, Rafael Subirán, Alicia Gil. Fibrosis avanzada asociada a esteatohepatitis no alcohólica (NASH) en España: resultados de un estudio Delphi. Gastroenterología y Hepatología 2024; 47(4) doi: 10.1016/j.gastrohep.2023.06.005
|
| 114 |
Uday Kumar Marri, Kumble Seetharama Madhusudhan. Dual-Energy Computed Tomography in Diffuse Liver Diseases. Journal of Gastrointestinal and Abdominal Radiology 2022; 5(02) doi: 10.1055/s-0042-1742432
|
| 115 |
Christiane Rennert, Theresa Heil, Gerda Schicht, Anna Stilkerich, Lena Seidemann, Victoria Kegel-Hübner, Daniel Seehofer, Georg Damm. Prolonged Lipid Accumulation in Cultured Primary Human Hepatocytes Rather Leads to ER Stress than Oxidative Stress. International Journal of Molecular Sciences 2020; 21(19) doi: 10.3390/ijms21197097
|
| 116 |
Marie Usal, Sylvie Veyrenc, Marie Darracq--Ghitalla-Ciock, Christophe Regnault, Sophie Sroda, Jean-Baptiste Fini, Muriel Raveton, Stéphane Reynaud. Exposure to a mixture of benzo[a]pyrene and triclosan induces multi-and transgenerational metabolic disorders associated with decreased female investment in reproduction in Silurana (Xenopus) tropicalis. Environmental Pollution 2022; 292 doi: 10.1016/j.envpol.2021.118418
|
| 117 |
MERTK+/hi M2c Macrophages Induced by Baicalin Alleviate Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2021; 22(19) doi: 10.3390/ijms221910604
|
| 118 |
Neelam Iftikhar, Abdullah Ijaz Hussain, Shahzad Ali Shahid Chatha, Nazia Sultana, Hassaan Anwer Rathore. Effects of polyphenol‐rich traditional herbal teas on obesity and oxidative stress in rats fed a high‐fat–sugar diet. Food Science & Nutrition 2022; 10(3) doi: 10.1002/fsn3.2695
|
| 119 |
Neelam Iftikhar, Abdullah Ijaz Hussain, Ghulam Mustafa Kamal, Sidra Manzoor, Tabinda Fatima, Farhan Khashim Alswailmi, Ashfaq Ahmad, Bader Alsuwayt, Sulaiman Mohammed Abdullah Alnasser. Antioxidant, Anti-Obesity, and Hypolipidemic Effects of Polyphenol Rich Star Anise (Illicium verum) Tea in High-Fat-Sugar Diet-Induced Obesity Rat Model. Antioxidants 2022; 11(11) doi: 10.3390/antiox11112240
|
| 120 |
Yiping Zhang, Longhe Yang, Nannan Zhao, Zhuan Hong, Bing Cai, Qingqing Le, Ting Yang, Lijun Shi, Jianlin He. Soluble Polysaccharide Derived from Laminaria japonica Attenuates Obesity-Related Nonalcoholic Fatty Liver Disease Associated with Gut Microbiota Regulation. Marine Drugs 2021; 19(12) doi: 10.3390/md19120699
|
| 121 |
G. Grzych, L. Bernard, R. Lestrelin, A. Tailleux, B. Staels. État des lieux sur la physiopathologie, le diagnostic et les traitements de la stéato-hépatite non alcoolique (NASH). Annales Pharmaceutiques Françaises 2023; 81(2) doi: 10.1016/j.pharma.2022.09.005
|
| 122 |
Yu-Wei Tsai, Zhuhuang Zhou, Cihun-Siyong Alex Gong, Dar-In Tai, Anca Cristea, Yu-Ching Lin, Ya-Chun Tang, Po-Hsiang Tsui. Ultrasound Detection of Liver Fibrosis in Individuals with Hepatic Steatosis Using the Homodyned K Distribution. Ultrasound in Medicine & Biology 2021; 47(1) doi: 10.1016/j.ultrasmedbio.2020.09.021
|
| 123 |
Tom Meyer, Johannes Castelein, Jakob Schattenfroh, Anna Sophie Morr, Rafaela Vieira da Silva, Heiko Tzschätzsch, Rolf Reiter, Jing Guo, Ingolf Sack. Magnetic resonance elastography in a nutshell: Tomographic imaging of soft tissue viscoelasticity for detecting and staging disease with a focus on inflammation. Progress in Nuclear Magnetic Resonance Spectroscopy 2024; doi: 10.1016/j.pnmrs.2024.05.002
|
| 124 |
Luis Alberto Ayala-Ruiz, Aram Josué García-Calderón, Oliver Rafid Magaña-Rodríguez, Adrián Sánchez-Orozco, Manuel López-Rodríguez, Joel E. López-Meza, Asdrubal Aguilera-Méndez, Patricia Rios-Chavez. Low-Dose, Long-Term Callistemon citrinus and Its Main Compounds Alter Hepatic Fatty Acid Profiles and Protect Liver Histology in Rats Fed a High-Fat–Sucrose Diet. International Journal of Molecular Sciences 2026; 27(16) doi: 10.3390/ijms27167255
|
| 125 |
David Hudson, Tamoor Afzaal, Hasan Bualbanat, Raaed AlRamdan, Nisha Howarth, Pavithra Parthasarathy, Alia AlDarwish, Emily Stephenson, Yousef Almahanna, Maytham Hussain, Luis Antonio Diaz, Juan Pablo Arab. Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241276334
|
| 126 |
Cheng-Wei Lu, Ming-Shyan Lin, Yu-Sheng Lin, I-Jen Chang, Ming-Horng Tsai, Kuo-Liang Wei, Mei-Yen Chen. Aminotransferase Ratio Is a Useful Index for Hepatosteatosis in Children and Adolescents. Gastroenterology Nursing 2019; 42(6) doi: 10.1097/SGA.0000000000000389
|
| 127 |
Tepparit Samrit, Supawadee Osotprasit, Athit Chaiwichien, Phawiya Suksomboon, Supanan Chansap, Anan Athipornchai, Narin Changklungmoa, Pornanan Kueakhai. Cold-Pressed Sacha Inchi Oil: High in Omega-3 and Prevents Fat Accumulation in the Liver. Pharmaceuticals 2024; 17(2) doi: 10.3390/ph17020220
|
| 128 |
Ying-Hsiu Lin, Yung-Liang Wan, Dar-In Tai, Jeng-Hwei Tseng, Chiao-Yin Wang, Yu-Wei Tsai, Yi-Ru Lin, Tu-Yung Chang, Po-Hsiang Tsui. Considerations of Ultrasound Scanning Approaches in Non-alcoholic Fatty Liver Disease Assessment through Acoustic Structure Quantification. Ultrasound in Medicine & Biology 2019; 45(8) doi: 10.1016/j.ultrasmedbio.2019.04.018
|
| 129 |
Elizabeth K. Johnston, Zhou Fang, Alejandro Soto-Gutierrez, C. Burcin Taner, Keith E. Cook, Liu Yang, Rosalyn D. Abbott. Engineering a three-dimensional liver steatosis model. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2025; 1871(6) doi: 10.1016/j.bbadis.2025.167888
|
| 130 |
Mark CC Cheah, Arthur J McCullough, George Boon-Bee Goh. Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease. Journal of Clinical and Translational Hepatology 2017; (XX) doi: 10.14218/JCTH.2017.00009
|
| 131 |
R. Bharath, P. Rajalakshmi, Mohammad Abdul Mateen. Multi-modal framework for automatic detection of diagnostically important regions in nonalcoholic fatty liver ultrasonic images. Biocybernetics and Biomedical Engineering 2018; 38(3) doi: 10.1016/j.bbe.2018.03.008
|
| 132 |
Naoya Igarashi, Kaichi Kasai, Yuki Tada, Koudai Kani, Miyuna Kato, Shun Takano, Kana Goto, Yudai Matsuura, Mayuko Ichimura-Shimizu, Shiro Watanabe, Koichi Tsuneyama, Yukihiro Furusawa, Yoshinori Nagai. Impacts of liver macrophages, gut microbiota, and bile acid metabolism on the differences in iHFC diet-induced MASH progression between TSNO and TSOD mice. Inflammation Research 2024; 73(7) doi: 10.1007/s00011-024-01884-7
|
| 133 |
Eduardo Fernández‐Martínez, Ivet G. Lira‐Islas, Raquel Cariño‐Cortés, Luis E. Soria‐Jasso, Elizabeth Pérez‐Hernández, Nury Pérez‐Hernández. Dietary chia seeds (Salvia hispanica) improve acute dyslipidemia and steatohepatitis in rats. Journal of Food Biochemistry 2019; 43(9) doi: 10.1111/jfbc.12986
|
| 134 |
Shahinul Alam, Mushfiqul Abrar, Saiful Islam, Mohammad Kamal, Mohammad J Hasan, Md. Abdullah S Khan, Nooruddin Ahmad. Effect of telmisartan and vitamin E on liver histopathology with non‐alcoholic steatohepatitis: A randomized, open‐label, noninferiority trial. JGH Open 2020; 4(4) doi: 10.1002/jgh3.12315
|
| 135 |
Ricardo Amorim, Carina C. Magalhães, Fernanda Borges, Paulo J. Oliveira, José Teixeira. From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria. Biology 2023; 12(4) doi: 10.3390/biology12040595
|
| 136 |
Linda Vanessa Márquez-Quiroga, Irina Cardoso-Lezama, Brisa Rodope Alarcón-Sánchez, Pamela Gaitán-González, Osiris Germán Idelfonso-García, Eduardo E. Vargas-Pozada, Carolina Piña-Vázquez, Erika Ramos-Tovar, Saúl Villa-Treviño, Jaime Arellanes-Robledo, Pablo Muriel. The progression of metabolic dysfunction-associated steatotic liver disease toward hepatocellular carcinoma in an efficient rat model. Biochemical Pharmacology 2025; 242 doi: 10.1016/j.bcp.2025.117369
|
| 137 |
R. Bharath, Pradeep Kumar Mishra, P. Rajalakshmi. Automated quantification of ultrasonic fatty liver texture based on curvelet transform and SVD. Biocybernetics and Biomedical Engineering 2018; 38(1) doi: 10.1016/j.bbe.2017.12.004
|
| 138 |
Xilin Li, Zemin Wang, James E. Klaunig. Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease. Toxicology 2018; 410 doi: 10.1016/j.tox.2018.08.007
|
| 139 |
Jheng-Ru Chen, Yi-Ping Chao, Yu-Wei Tsai, Hsien-Jung Chan, Yung-Liang Wan, Dar-In Tai, Po-Hsiang Tsui. Clinical Value of Information Entropy Compared with Deep Learning for Ultrasound Grading of Hepatic Steatosis. Entropy 2020; 22(9) doi: 10.3390/e22091006
|
| 140 |
Prahlad K. Rao, Kate Merath, Eugene Drigalenko, Avinash Y. L. Jadhav, Richard A. Komorowski, Matthew I. Goldblatt, Anand Rohatgi, Mark A. Sarzynski, Samer Gawrieh, Michael Olivier. Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease. Clinical Proteomics 2018; 15(1) doi: 10.1186/s12014-018-9186-0
|
| 141 |
Célio Junior da Costa Fernandes, Vivian Cristina da Cruz Rodrigues, Gustavo José de Sá Pereira, Diego Gomes de Melo, Thaís Dantis Pereira de Campos, Raphael dos Santos Canciglieri, Rodrigo Augusto Foganholi da Silva, Adelino Sanchez Ramos da Silva, José Rodrigo Pauli, Atan Gross, Leandro Pereira de Moura. Epigenetically modulated MTCH2 and regulated ATP5 in the liver of obese mice subjected to strength training. Life Sciences 2026; 384 doi: 10.1016/j.lfs.2025.124105
|
| 142 |
Chigusa Kikuchi, Akiko Sakasai-Sakai, Risa Okimura, Hinako Tanaka, Takanobu Takata, Masayoshi Takeuchi, Tamihide Matsunaga. Accumulation of Toxic Advanced Glycation End-Products Induces Cytotoxicity and Inflammation in Hepatocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells. Biological and Pharmaceutical Bulletin 2021; 44(10) doi: 10.1248/bpb.b21-00520
|
| 143 |
Savinda Liyanagedera, Robert Patrick Williams, Silvio Veraldi, Valerio Nobili, Jake P. Mann. The pharmacological management of NAFLD in children and adolescents. Expert Review of Clinical Pharmacology 2017; 10(11) doi: 10.1080/17512433.2017.1365599
|
| 144 |
Keishi Kisoh, Go Sugahara, Yuko Ogawa, Suzue Furukawa, Yuji Ishida, Takeshi Okanoue, Michinori Kohara, Chise Tateno. Estimating Drug Efficacy with a Diet-Induced NASH Model in Chimeric Mice with Humanized Livers. Biomedicines 2021; 9(11) doi: 10.3390/biomedicines9111647
|
| 145 |
Chun‐Hsien Chiang, Ting-Rui Zhang, Pu‐Sheng Hsu, Shau‐Ping Lin, Ching‐Yi Chen. Weight regain, but not weight loss exacerbates hepatic fibrosis during multiple weight cycling events in male mice. European Journal of Nutrition 2024; 63(3) doi: 10.1007/s00394-024-03326-w
|
| 146 |
Zhi-Chun Zhang, Xiao-Long Guo, Xi Li. The novel roles of circular RNAs in metabolic organs. Genes & Diseases 2018; 5(1) doi: 10.1016/j.gendis.2017.12.002
|
| 147 |
Seul Ki Han, Soon Koo Baik, Moon Young Kim. Non-alcoholic fatty liver disease: Definition and subtypes. Clinical and Molecular Hepatology 2023; 29(Suppl) doi: 10.3350/cmh.2022.0424
|
| 148 |
Maria-Eleni Kouridaki, Jonathan Gillespie, John Robinson, Tanya Mathie, Laura Bain, Duncan McArthur, Angus Morrison, Daniel B. Greenslade, Michail Papadourakis, Kasia Maj, Kate Cameron, Darryl Turner, Scott P. Webster, Martin A. Wear, Dahlia Doughty-Shenton, Alison N. Hulme, Julien Michel. Optimization of Cyclophilin B-Targeted Tri-vector Inhibitors for Novel MASH Treatments. Journal of Medicinal Chemistry 2025; 68(6) doi: 10.1021/acs.jmedchem.5c00301
|
| 149 |
Shao-Wen Weng, Jian-Ching Wu, Feng-Chih Shen, Yen-Hsiang Chang, Yu-Jih Su, Wei-Shiung Lian, Ming-Hong Tai, Chia-Hao Su, Jiin-Haur Chuang, Tsu-Kung Lin, Chia-Wei Liou, Tian-Huei Chu, Ying-Hsien Kao, Feng-Sheng Wang, Pei-Wen Wang. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation. Diabetologia 2023; 66(5) doi: 10.1007/s00125-023-05869-9
|
| 150 |
Zhenyu Wang, Yang Yang, Jiawen Zhang, Jiamiao Hu, Xin Yan, Shaoxiao Zeng, Xiujuan Huang, Shaoling Lin. Ferulic acid ameliorates intrahepatic triglyceride accumulation in vitro but not in high fat diet-fed C57BL/6 mice. Food and Chemical Toxicology 2021; 149 doi: 10.1016/j.fct.2021.111978
|
| 151 |
R. Dangarembizi Dangarembizi, P. Nkomozepi Nkomozepi, R. Ndou Ndou. Type 2 diabetes mellitus-related non-alcoholic steatohepatitis in the Zucker Diabetic Sprague Dawley rat. The Journal of Medical Laboratory Science and Technology of South Africa 2020; 2(2) doi: 10.36303/JMLSTSA.2020.2.2.55
|
| 152 |
Giuseppe Derosa, Pamela Maffioli. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; doi: 10.1007/978-94-007-7675-3_23
|
| 153 |
Takao Nagashima, Yasuyuki Kamata, Masahiro Iwamoto, Hitoaki Okazaki, Noriyoshi Fukushima, Seiji Minota. Liver dysfunction in anti-melanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis. Rheumatology International 2019; 39(5) doi: 10.1007/s00296-019-04255-2
|
| 154 |
Terence N Moyana. Metabolic dysfunction-associated steatotic liver disease: The question of long-term high-normal alanine aminotransferase as a screening test. World Journal of Gastroenterology 2024; 30(42): 4576-4582 doi: 10.3748/wjg.v30.i42.4576
|
| 155 |
Jakkapong Inchai, Manussabhorn Phatsara, Ratchadaporn Yoonakorn, Pannita Holasut, Thanthakan Saithong, Kornwalai Tunkaew, Atcharaporn Ontawong, Thippawan Yasanga, Nitra Nuengchamnong, Narissara Lailerd, Doungporn Amornlerdpison, Chutima S. Vaddhanaphuti. Lipid-lowering and hepatoprotective effects of Ocimum sanctum L. (Thai holy basil) flower against MASLD and liver inflammation in rats. Food Research International 2026; 242 doi: 10.1016/j.foodres.2026.119968
|
| 156 |
Britt Blokker, Cristiano Bortoluzzi, Christelle Iaconis, Estefania Perez-Calvo, Maria C. Walsh, Ghislain Schyns, Ian Tamburini, Jack M. Geremia. Evaluation of a Novel Precision Biotic on Enterohepatic Health Markers and Growth Performance of Broiler Chickens under Enteric Challenge. Animals 2022; 12(19) doi: 10.3390/ani12192502
|
| 157 |
Gabriel Mejia, Paula Cárdenas, Daniela Ruiz, Angela Castillo, Pablo Arbeláez. SEPAL: Spatial Gene Expression Prediction from Local Graphs. 2023 IEEE/CVF International Conference on Computer Vision Workshops (ICCVW) 2023; doi: 10.1109/ICCVW60793.2023.00243
|
| 158 |
Hardika S Vegda, Bhavin Patel, Gaurav A Girdhar, Mohd. Shabankhan H Pathan, Rahnuma Ahmad, Mainul Haque, Susmita Sinha, Santosh Kumar. Role of Nonalcoholic Fatty Liver Disease in Periodontitis: A Bidirectional Relationship. Cureus 2024; doi: 10.7759/cureus.63775
|
| 159 |
Mohammad Hassan Baig, Preeti Gupta, Mohd. Imran Khan, Mohamed F. Alajmi, Afzal Hussain, Md. Imtaiyaz Hassan, Jae-June Dong. Probing the Interaction of Selonsertib with Human Serum Albumin: In
silico and In vitro Approaches. Current Topics in Medicinal Chemistry 2022; 22(10) doi: 10.2174/1568026622666220330012032
|
| 160 |
Muhammad Nadeem Aslam, Christine M. Bassis, Li Zhang, Sameer Zaidi, James Varani, Ingrid L. Bergin, Valerio Pazienza. Calcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles. PLOS ONE 2016; 11(11) doi: 10.1371/journal.pone.0166178
|
| 161 |
Marie Usal, Sylvie Veyrenc, Marie Darracq--Ghitalla-Ciock, Christophe Regnault, Sophie Sroda, Jean-Baptiste Fini, Cécile Canlet, Marie Tremblay-Franco, Muriel Raveton, Stéphane Reynaud. Transgenerational metabolic disorders and reproduction defects induced by benzo[a]pyrene in Xenopus tropicalis. Environmental Pollution 2021; 269 doi: 10.1016/j.envpol.2020.116109
|
| 162 |
Marie Usal, Christophe Regnault, Sylvie Veyrenc, Karine Couturier, Cécile Batandier, Anne-Laure Bulteau, David Lejon, Bruno Combourieu, Thomas Lafond, Muriel Raveton, Stéphane Reynaud. Concomitant exposure to benzo[a]pyrene and triclosan at environmentally relevant concentrations induces metabolic syndrome with multigenerational consequences in Silurana (Xenopus) tropicalis. Science of The Total Environment 2019; 689 doi: 10.1016/j.scitotenv.2019.06.386
|
| 163 |
Yuan Yuan, Hisao Naito, Xiaofang Jia, Kazuya Kitamori, Tamie Nakajima. Combination of Hypertension Along with a High Fat and Cholesterol Diet Induces Severe Hepatic Inflammation in Rats via a Signaling Network Comprising NF-κB, MAPK, and Nrf2 Pathways. Nutrients 2017; 9(9) doi: 10.3390/nu9091018
|
| 164 |
Chanbin Lee, Jieun Kim, Youngmi Jung. Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Cells 2019; 8(10) doi: 10.3390/cells8101259
|
| 165 |
Menno Hoekstra, Joya E. Nahon, Laura M. de Jong, Mara J. Kröner, Lidewij R. de Leeuw, Miranda Van Eck. Inhibition of PRMT3 activity reduces hepatic steatosis without altering atherosclerosis susceptibility in apoE knockout mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(6) doi: 10.1016/j.bbadis.2019.02.012
|
| 166 |
Nikolaus Berndt, Erik Kolbe, Robert Gajowski, Johannes Eckstein, Fritzi Ott, David Meierhofer, Hermann‐Georg Holzhütter, Madlen Matz‐Soja. Functional Consequences of Metabolic Zonation in Murine Livers: Insights for an Old Story. Hepatology 2021; 73(2) doi: 10.1002/hep.31274
|
| 167 |
Clint M. Upchurch, Scott Yeudall, Caitlin M. Pavelec, Dennis Merk, Jan Greulich, Mohan Manjegowda, Shyam S. Raghavan, Irina M. Bochkis, Michael M. Scott, Edward Perez-Reyes, Norbert Leitinger. Targeting oxidized phospholipids by AAV-based gene therapy in mice with established hepatic steatosis prevents progression to fibrosis. Science Advances 2022; 8(28) doi: 10.1126/sciadv.abn0050
|
| 168 |
Lisa Morisseau, Valérie Pawlowski, Valérie Plaisance, Mathilde Lucas, Cécile Legallais, Yasuyuki Sakai, Amar Abderrahmani, Rachid Jellali, Eric Leclerc. Identification of the differential and synergic lipotoxic patterns of oleic acid, palmitic acid, and their mixture in 3D HepG2/C3A tissue using liver‐on‐chip technology. Biotechnology Progress 2026; 42(1) doi: 10.1002/btpr.70075
|
| 169 |
L. V. Tarasova, V. N. Diomidova, N. V. Tolmacheva, Yu. V. Tsyganova, A. L. Ivanova, J. V. Maslova, E. V. Barsukova. Correlation of secreted frizzled related protein-4 adipokin expression and expression of fatty liver changes under the conditions of a chronic experiment. Experimental and Clinical Gastroenterology 2021; 1(5) doi: 10.31146/1682-8658-ecg-189-5-44-48
|
| 170 |
Salvatore Sciacchitano, Luca Lavra, Alessandra Morgante, Alessandra Ulivieri, Fiorenza Magi, Gian De Francesco, Carlo Bellotti, Leila Salehi, Alberto Ricci. Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z. International Journal of Molecular Sciences 2018; 19(2) doi: 10.3390/ijms19020379
|
| 171 |
Jonathan Mertens, Christophe De Block, Maarten Spinhoven, Ann Driessen, Sven M. Francque, Wilhelmus J. Kwanten. Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.768576
|
| 172 |
Arthur Cens, Bart Staels, Réjane Paumelle. La ballonisation hépatocytaire : une nouvelle cible thérapeutique dans la Physiopathologie de la MASH. Revue Francophone des Laboratoires 2026; 2026(579) doi: 10.1016/S1773-035X(26)76566-7
|
| 173 |
Ramin Tavakoli, Mohammad Hasan Maleki, Omid Vakili, Motahareh Taghizadeh, Fatemeh Zal, Sayed Mohammad Shafiee. Bilirubin, once a toxin but now an antioxidant alleviating non-alcoholic fatty liver disease in an autophagy-dependent manner in high-fat diet-induced rats: a molecular and histopathological analysis. Research in Pharmaceutical Sciences 2024; 19(4) doi: 10.4103/RPS.RPS_53_24
|
| 174 |
Xiaomin Zheng, Zhe Zhang, Xuwen Jiao, Mao Mu, Ang Liu, Yao Huang, Weiping Wu, Chuanrong Liao, Yuhui Jiang, Weiyang Liang, Shan Li, Jing Li, Lei Zhang. Discovery of a pyrimidine-based steroidal FXR agonist for the treatment of metabolic dysfunction-associated steatotic liver disease. Bioorganic Chemistry 2026; 174 doi: 10.1016/j.bioorg.2026.109721
|
| 175 |
Naimish N. Mehta, Manmohan Rajput, Karan Kumar, Anand Nagar, Vinay K. Mahala, Vivek A. Saraswat, Akash Mishra. Evaluation of Controlled Attenuation Parameter as a Tool for Assessment of Hepatic Steatosis in Living Liver Donors. Journal of Clinical and Experimental Hepatology 2025; 15(4) doi: 10.1016/j.jceh.2025.102514
|
| 176 |
Stéphanie A. Eid, Pongrat Jaisil, Kai Guo, John M. Hayes, Crystal Pacut, Diana M. Rigan, Andrew Carter, Samuel J. Teener, Bhumsoo Kim, Chloe Kiriluk, William Lentz, Cameron M. Miller, Ian Webber-Davis, Haley McQuown, Dae-Gyu Jang, Adam Patterson, Emily J. Koubek, Dave Bridges, Junguk Hur, Jacob D. Meyer, Eva L. Feldman. Ketogenic Diet and Exercise Improve Peripheral Neuropathy in a Mouse Model of Metabolic Syndrome. Diabetes 2026; 75(6) doi: 10.2337/db25-1015
|
| 177 |
Afaf Benhouda, Massinissa Yahia, Zina Allaoua, Djahida Benhouda, Oussama Khaoua, Noura Benbellat. In silico exploration of carvacrol's anti-infective, anti-inflammatory and antihyperlipidemic mechanisms. Bioorganic Chemistry 2026; 180 doi: 10.1016/j.bioorg.2026.110224
|
| 178 |
Rosângela Passos de Jesus, Naiara Brunelle Oliveira Neiva, Thomas Thássio Rodrigues de Araújo Silva. A síndrome metabólica e suas implicações clínicas. 2018; doi: 10.7476/9786588211113.0007
|
| 179 |
Fahrettin Haczeyni, Matthew M Yeh, George N Ioannou, Isabelle A Leclercq, Robert Goldin, Yock Young Dan, Jun Yu, Narcissus C Teoh, Geoffrey C Farrell. Mouse models of non‐alcoholic steatohepatitis: A reflection on recent literature. Journal of Gastroenterology and Hepatology 2018; 33(7) doi: 10.1111/jgh.14122
|
| 180 |
Falguni Mishra, Yi Yuan, Jenny J. Yang, Bin Li, Payton Chan, Zhiren Liu. Depletion of Activated Hepatic Stellate Cells and Capillarized Liver Sinusoidal Endothelial Cells Using a Rationally Designed Protein for Nonalcoholic Steatohepatitis and Alcoholic Hepatitis Treatment. International Journal of Molecular Sciences 2024; 25(13) doi: 10.3390/ijms25137447
|
| 181 |
Torsten Diesinger, Alfred Lautwein, Vyacheslav Buko, Elena Belonovskaya, Oksana Lukivskaya, Elena Naruta, Siarhei Kirko, Viktor Andreev, Radovan Dvorsky, Dominik Buckert, Sebastian Bergler, Christian Renz, Dieter Müller‐Enoch, Thomas Wirth, Thomas Haehner. ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis. Physiological Reports 2021; 9(6) doi: 10.14814/phy2.14795
|
| 182 |
Michael L. Attanasi, Mathew J. Gregoski, Don C. Rockey. MELD and the Risk of Mortality Between Black and White Patients with Advanced Fibrosis. Digestive Diseases and Sciences 2026; doi: 10.1007/s10620-026-10130-5
|
| 183 |
Ahmed M Abo-khookh, Hamdy A Ghoneim, Rania R Abdelaziz, Manar A Nader, Noha M Shawky. The dual inhibitor Sacubitril-valsartan ameliorate high-fat high-fructose-induced metabolic disorders in rats superiorly compared to valsartan only. Journal of Pharmacy and Pharmacology 2023; 75(6) doi: 10.1093/jpp/rgad012
|
| 184 |
Yuchang Li, Liting Chen, Vassilios Papadopoulos. The mitochondrial translocator protein (TSPO, 18 kDa): A key multifunctional molecule in liver diseases. Biochimie 2024; 224 doi: 10.1016/j.biochi.2023.11.013
|
| 185 |
Suzanne Madgwick, Saimir Luli, Helene Sellier, Jacqueline A. Butterworth, Jack Leslie, Adam J. Moore, Emma K. Corbin, Adrian I. Yemm, Robson T. Chiremba, Dina Tiniakos, Fiona Oakley, Neil D. Perkins, Jill E. Hunter. Claspin haploinsufficiency leads to defects in fertility, hyperplasia and an increased oncogenic potential. Biochemical Journal 2022; 479(19) doi: 10.1042/BCJ20220101
|
| 186 |
Jörn M. Schattenberg, Maria-Magdalena Balp, Brenda Reinhart, Andreas Tietz, Stephane A. Regnier, Gorana Capkun, Qin Ye, Jürgen Loeffler, Marcos C. Pedrosa, Matt Docherty. NASHmap: clinical utility of a machine learning model to identify patients at risk of NASH in real-world settings. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32551-2
|
| 187 |
Putri Anggreini, Hadi Kuncoro, Sri Sumiwi, Jutti Levita. Lygodium microphyllum Inhibits de Novo Lipogenesis Activity in the Hepatocytes of High-Fat High-Fructose-Induced Rats by Increasing the Levels of SIRT1 and AMPK. Journal of Experimental Pharmacology 2024; doi: 10.2147/JEP.S473763
|
| 188 |
Tanvi Singla, Komal N Muneshwar, Aniket G Pathade, Seema Yelne. Hepatocytic Ballooning in Non-alcoholic Steatohepatitis: Bridging the Knowledge Gap and Charting Future Avenues. Cureus 2023; doi: 10.7759/cureus.45884
|
| 189 |
Basile Njei, Eri Osta, Nelvis Njei, Yazan A. Al-Ajlouni, Joseph K. Lim. An explainable machine learning model for prediction of high-risk nonalcoholic steatohepatitis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-59183-4
|
| 190 |
Ana Letícia Rocha Lima Caxambú, Marília Martins Silveira Carrocini, Fulvio Clemo Santos Thomazelli. PREVALÊNCIA DAS ALTERAÇÕES DE ENZIMAS HEPÁTICAS RELACIONADAS À DOENÇA HEPÁTICA GORDUROSA NÃO-ALCOÓLICA EM PACIENTES COM DIABETES MELLITUS. Arquivos Catarinenses de Medicina 2016; 44(1) doi: 10.63845/5hsc3n41
|
| 191 |
Hongjiao Xiang, Mingmei Shao, Yifei Lu, Junmin Wang, Tao Wu, Guang Ji. Kaempferol Alleviates Steatosis and Inflammation During Early Non-Alcoholic Steatohepatitis Associated With Liver X Receptor α-Lysophosphatidylcholine Acyltransferase 3 Signaling Pathway. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.690736
|
| 192 |
Xiying Zhang, Fang Deng, Yuping Zhang, Xiaohong Zhang, Jianfei Chen, Youzhao Jiang. PPARγ attenuates hepatic inflammation and oxidative stress of non‑alcoholic steatohepatitis via modulating the miR‑21‑5p/SFRP5 pathway. Molecular Medicine Reports 2021; 24(5) doi: 10.3892/mmr.2021.12463
|
| 193 |
Aastha Arora, Gustavo Luis Tripodi, Ilona Kareinen, Martin Berg, Maria Josefa Forteza, Anton Gisterå, Silke Griepke, Felipe Beccaria Casagrande, Joilson O. Martins, Dulcineia Saes Parra Abdalla, Jennifer Cole, Claudia Monaco, Daniel F. J. Ketelhuth. Genetic Deficiency of Indoleamine 2,3-dioxygenase Aggravates Vascular but Not Liver Disease in a Nonalcoholic Steatohepatitis and Atherosclerosis Comorbidity Model. International Journal of Molecular Sciences 2022; 23(9) doi: 10.3390/ijms23095203
|
| 194 |
Kate Šešelja, Iva Bazina, Milka Vrecl, Jessica Welss, Martin Schicht, Martina Mihalj, Vjekoslav Kopačin, Friedrich Paulsen, Tatjana Pirman, Mirela Baus Lončar. Tff3 Deficiency Protects against Hepatic Fat Accumulation after Prolonged High-Fat Diet. Life 2022; 12(8) doi: 10.3390/life12081288
|
| 195 |
Helena Solleiro-Villavicencio, Lucía Angélica Méndez-García, Nydia A. Ocampo-Aguilera, Itzel Baltazar-Pérez, José A. Arreola-Miranda, José A. Aguayo-Guerrero, Ana Alfaro-Cruz, Antonio González-Chávez, Miguel A. Fonseca-Sánchez, José Manuel Fragoso, Galileo Escobedo. Decreased Hepatic and Serum Levels of IL-10 Concur with Increased Lobular Inflammation in Morbidly Obese Patients. Medicina 2024; 60(6) doi: 10.3390/medicina60060862
|
| 196 |
Itzayana Rodríguez-Antonio, Guillermo N. López-Sánchez, Victor Y. Garrido-Camacho, Misael Uribe, Norberto C. Chávez-Tapia, Natalia Nuño-Lámbarri. Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development. HPB 2020; 22(11) doi: 10.1016/j.hpb.2020.07.011
|
| 197 |
Irma Catalina Soto‐Luna, Pedro Macedonio García‐López, Belinda Vargas‐Guerrero, Tereso Jovany Guzmán, José Alfredo Domínguez‐Rosales, Carmen Magdalena Gurrola‐Díaz. Lupin protein isolate improves insulin sensitivity and steatohepatitis in vivo and modulates the expression of the Fasn, Gys2, and Gsk3b genes. Food Science & Nutrition 2021; 9(5) doi: 10.1002/fsn3.2206
|
| 198 |
Csilla Ari, Dominic P. D’Agostino. Divergent Hepatic Outcomes of Chronic Ketone Supplementation: Ketone Salts Preserve Liver Health While Ketone Esters and Precursors Drive Inflammation and Steatosis. Pharmaceuticals 2025; 18(10) doi: 10.3390/ph18101436
|
| 199 |
Tatsuya Yamada, Daisuke Murata, David E. Kleiner, Robert Anders, Avi Z. Rosenberg, Jeffrey Kaplan, James P. Hamilton, Mariam Aghajan, Moshe Levi, Nae-Yuh Wang, Ted M. Dawson, Toru Yanagawa, Andrew F. Powers, Miho Iijima, Hiromi Sesaki. Prevention and regression of megamitochondria and steatosis by blocking mitochondrial fusion in the liver. iScience 2022; 25(4) doi: 10.1016/j.isci.2022.103996
|
| 200 |
Sukanya Jaroenporn, Taratorn Fainanta, Kanitha Tananuwong, Watthanachai Saradhuldhat, Thapanan Jatuyosporn, Kuakarun Krusong. Cassava-resistant starch type 3 modulates high-fat diet-induced adiposity and transcriptional oxidative stress imbalance. Nutrition Research 2026; 150 doi: 10.1016/j.nutres.2026.04.006
|
| 201 |
Fengying Yuan, Bingya Wang, Ji-Ting Hou, Jiali Li, Jianliang Shen, Yi Duan, Wen Xiu Ren, Shan Wang. Demonstrating HOCl as a potential biomarker for liver fibrosis using a highly sensitive fluorescent probe. Sensors and Actuators B: Chemical 2023; 378 doi: 10.1016/j.snb.2022.133219
|
| 202 |
Eun Bok Baek, Jaeku Lee, Ji-Hee Hwang, Heejin Park, Byoung-Seok Lee, Yong-Bum Kim, Sang-Yeop Jun, Jun Her, Hwa-Young Son, Jae-Woo Cho. Application of multiple-finding segmentation utilizing Mask R-CNN-based deep learning in a rat model of drug-induced liver injury. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-44897-8
|
| 203 |
Andrea Peloso, Matthieu Tihy, Beat Moeckli, Laura Rubbia-Brandt, Christian Toso. Clearing Steatosis Prior to Liver Surgery for Colorectal Metastasis: A Narrative Review and Case Illustration. Nutrients 2022; 14(24) doi: 10.3390/nu14245340
|
| 204 |
Mustafa Oruc, Mustafa Emre Gedik, Meral Uner, Elif Ulug, Reyhan Nergiz Unal, Gurcan Gunaydin, Ahmet Bulent Dogrul. Effectiveness of metformin for the reversal of cold-ischemia-induced damage in hepatosteatosis. Clinics and Research in Hepatology and Gastroenterology 2024; 48(4) doi: 10.1016/j.clinre.2024.102314
|
| 205 |
Céline Drai, Andrea Chierici, Giovanna Pavone, Dorith Benamran, Mohamed Alromayan, Abdulrhamane Alamri, Rodolphe Anty, Guido Liddo, Antonio Iannelli. Remission of nonalcoholic steatohepatitis after bariatric surgery: a single referral center cohort study. Surgery for Obesity and Related Diseases 2024; 20(5) doi: 10.1016/j.soard.2023.10.015
|
| 206 |
Monica F Torrez Lamberti, Sharon Thompson, Natalie A Harrison, Christopher L Gardner, Danilo R da Silva, Leandro D Teixeira, Kanthi Kiran Kondepudi, Claudio F Gonzalez, Sasanka S Chukkapalli, Graciela L Lorca.
Lactobacillus johnsonii N6.2 improves glycemia and reduces diabetes-induced organ injury in the db/db mice model. Journal of Endocrinology 2025; 267(1) doi: 10.1530/JOE-25-0184
|
| 207 |
Katarzyna Bergmann, Anna Stefanska, Magdalena Krintus, Lukasz Szternel, Wojciech J. Bilinski, Przemyslaw T. Paradowski, Grazyna Sypniewska. Diagnostic Performance of Biomarker-Based Scores as Predictors of Metabolic Dysfunction-Associated Fatty Liver Disease Risk in Healthy Children. Nutrients 2023; 15(16) doi: 10.3390/nu15163667
|
| 208 |
Jieun Moon, Pilhan Kim. Intravital Two-photon Imaging of Dynamic Alteration of Hepatic Lipid Droplets in Fasted and Refed State. Journal of Lipid and Atherosclerosis 2021; 10(3) doi: 10.12997/jla.2021.10.3.313
|
| 209 |
Hend Ashour, Laila A. Rashed, Radwa T. M. Hassanein, Basma E. Aboulhoda, Hasnaa A. Ebrahim, Mohamed H. Elsayed, Miran A. Elkordy, Omaima M. Abdelwahed. Thymoquinone and quercetin protect against hepatic steatosis in association with SIRT1/AMPK stimulation and regulation of autophagy, perilipin-2, and cytosolic lipases. Archives of Physiology and Biochemistry 2023; 129(1) doi: 10.1080/13813455.2022.2134423
|
| 210 |
Karlo Mladenić, Maja Lenartić, Sonja Marinović, Bojan Polić, Felix M. Wensveen. The “Domino effect” in MASLD: The inflammatory cascade of steatohepatitis. European Journal of Immunology 2024; 54(4) doi: 10.1002/eji.202149641
|
| 211 |
Niketa Sharma, Swarupa Chakole, Bhushan Wandile. Uncovering the Cardiovascular Threat: A Comprehensive Examination of Liver Fibrosis and Subclinical Atherosclerosis in Non-alcoholic Fatty Liver Disease. Cureus 2023; doi: 10.7759/cureus.46946
|
| 212 |
Nanxuan Luo, Changqing Yang, Yurong Zhu, Qianfeng Chen, Baoshun Zhang. Diosmetin Ameliorates Nonalcoholic Steatohepatitis through Modulating Lipogenesis and Inflammatory Response in a STAT1/CXCL10-Dependent Manner. Journal of Agricultural and Food Chemistry 2021; 69(2) doi: 10.1021/acs.jafc.0c06652
|
| 213 |
Ayesha Monga Kravetz, Todd Testerman, Brittany Galuppo, Joerg Graf, Bridget Pierpont, Stephan Siebel, Richard Feinn, Nicola Santoro. Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth. The Journal of Clinical Endocrinology & Metabolism 2020; 105(10) doi: 10.1210/clinem/dgaa382
|
| 214 |
Stephen A. Harrison, Peter J. Ruane, Bradley Freilich, Guy Neff, Rashmee Patil, Cynthia Behling, Chen Hu, Reshma Shringarpure, Brittany de Temple, Erica Fong, Erik J. Tillman, Timothy Rolph, Andrew Cheng, Kitty Yale. A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis. JHEP Reports 2023; 5(1) doi: 10.1016/j.jhepr.2022.100563
|
| 215 |
Robert Nastasa, Carol Stanciu, Sebastian Zenovia, Ana-Maria Singeap, Camelia Cojocariu, Catalin Sfarti, Irina Girleanu, Stefan Chiriac, Tudor Cuciureanu, Laura Huiban, Cristina-Maria Muzica, Anca Trifan. The Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students. Diagnostics 2021; 11(12) doi: 10.3390/diagnostics11122341
|
| 216 |
Martina Hüttl, Irena Markova, Denisa Miklankova, Iveta Zapletalova, Martin Poruba, Zuzana Racova, Rostislav Vecera, Hana Malinska. The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model. Pharmaceutics 2021; 14(1) doi: 10.3390/pharmaceutics14010045
|
| 217 |
Yuchang Li, Liting Chen, Lu Li, Chantal Sottas, Stephanie K. Petrillo, Anthoula Lazaris, Peter Metrakos, Hangyu Wu, Yuji Ishida, Takeshi Saito, Lucy Golden-Mason, Hugo R. Rosen, Jeremy J. Wolff, Cristina I. Silvescu, Samuel Garza, Garett Cheung, Tiffany Huang, Jinjiang Fan, Martine Culty, Bangyan Stiles, Kinji Asahina, Vassilios Papadopoulos. Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease. iScience 2021; 24(5) doi: 10.1016/j.isci.2021.102457
|
| 218 |
Hyeonji Kim, Kippeum Lee, Ju-Yeon Kim, Jae-Jung Shim, Junghyun Lim, Joo-Yun Kim, Jung-Lyoul Lee. Lactobacillus helveticus Isolated from Raw Milk Improves Liver Function, Hepatic Steatosis, and Lipid Metabolism in Non-Alcoholic Fatty Liver Disease Mouse Model. Microorganisms 2023; 11(10) doi: 10.3390/microorganisms11102466
|
| 219 |
Megan Sedeman, Claudia Christowitz, Louis de Jager, Anna-Mart Engelbrecht. Obese mammary tumour-bearing mice are highly sensitive to doxorubicin-induced hepatotoxicity. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10189-z
|
| 220 |
Yoon-su Ha, Taek-Kyong Kim, Jun Heo, Jintaek Oh, Seung-Kyoon Kim, Jeongkyu Kim, Jeonghyung Lee, Se-Ran Yang, Seonghwan Hwang, Seung-Jin Kim. Rocaglamide-A mitigates LPS-induced hepatic inflammation by modulating JNK/AP-1 signaling cascade and ROS production in hepatocytes. Toxicological Research 2025; 41(1) doi: 10.1007/s43188-024-00263-y
|
| 221 |
Nelson Andrade, Ilda Rodrigues, Francisca Carmo, Gabriela Campanher, Isabella Bracchi, Joanne Lopes, Emília Patrício, João T. Guimarães, Juliana A. Barreto-Peixoto, Anabela S. G. Costa, Liliana Espírito Santo, Marlene Machado, Thiago F. Soares, Susana Machado, Maria Beatriz P. P. Oliveira, Rita C. Alves, Fátima Martel, Cláudia Silva. Sustainable Utilization of Coffee Pulp, a By-Product of Coffee Production: Effects on Metabolic Syndrome in Fructose-Fed Rats. Antioxidants 2025; 14(3) doi: 10.3390/antiox14030266
|
| 222 |
Nahla Mohammed Abd El-Hameed, S.A. Abd El-Aleem, Mahmoud A. Khattab, Azza Hussein Ali, Hanaa Hassanein Mohammed. Curcumin activation of nuclear factor E2-related factor 2 gene (Nrf2): Prophylactic and therapeutic effect in nonalcoholic steatohepatitis (NASH). Life Sciences 2021; 285 doi: 10.1016/j.lfs.2021.119983
|
| 223 |
Bertrand Cariou, Christopher D. Byrne, Rohit Loomba, Arun J. Sanyal. Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review. Diabetes, Obesity and Metabolism 2021; 23(5) doi: 10.1111/dom.14322
|
| 224 |
Benjamin J. Moyer, Itzel Y. Rojas, Joanna S. Kerley-Hamilton, Haley F. Hazlett, Krishnamurthy V. Nemani, Heidi W. Trask, Rachel J. West, Leslie E. Lupien, Alan J. Collins, Carol S. Ringelberg, Barjor Gimi, William B. Kinlaw, Craig R. Tomlinson. Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1. Toxicology and Applied Pharmacology 2016; 300 doi: 10.1016/j.taap.2016.03.011
|
| 225 |
Xue Yang, Hui Chang, Limei Feng, Bin Wang. Knowledge, attitude, and practice towards fatty liver disease among the general population in Shanghai, China: a community-based cross-sectional study. Frontiers in Public Health 2026; 14 doi: 10.3389/fpubh.2026.1844298
|
| 226 |
Patcharamon Seubnooch, Matteo Montani, Jean-Francois Dufour, Mojgan Masoodi. Spatial lipidomics reveals zone-specific hepatic lipid alteration and remodeling in metabolic dysfunction-associated steatohepatitis. Journal of Lipid Research 2024; 65(9) doi: 10.1016/j.jlr.2024.100599
|
| 227 |
Ashmita Saigal, Desiree Abdurrachim, Emily Tso, Christopher Hendra, Charlene Zhi Lin Ong, Sonya Kimball, Wendy Blumenschein, Yang Liu, Xueyuan Jiang, Arun J. Sanyal, Asad Abu Bakar Ali, Saswata Talukdar. AI digital pathology as a key tool providing in-depth understanding of the progression and regression of MASH and fibrosis in male mouse models. Nature Communications 2026; 17(1) doi: 10.1038/s41467-026-73370-z
|
| 228 |
Geoffrey Omuse, Daniel Maina, Mariza Hoffman, Jane Mwangi, Caroline Wambua, Elizabeth Kagotho, Angela Amayo, Peter Ojwang, Zulfiqarali Premji, Kiyoshi Ichihara, Rajiv Erasmus. Metabolic syndrome and its predictors in an urban population in Kenya: A cross sectional study. BMC Endocrine Disorders 2017; 17(1) doi: 10.1186/s12902-017-0188-0
|
| 229 |
Noha A.T. Abbas, Fawkia A. Fayed, Rabab Saber El Sebaey, Heba A. Hassan. Telmisartan and candesartan promote browning of white adipose tissue and reverse fatty liver changes in high fat diet fed male albino rats. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(4) doi: 10.1007/s00210-023-02771-4
|
| 230 |
Moyuka Kubota-Takamori, Kazuhiro Omori, Chiaki Kamei-Nagata, Fumiko Kiyama, Takayuki Ishii, Masaaki Nakayama, Kazuyoshi Gotoh, Kimito Hirai, Yuki Shinoda-Ito, Keisuke Okubo, Shin Nakamura, Atsushi Ikeda, Tsugumichi Saito, Jun Wada, Shogo Takashiba. Continuous glucose monitoring reveals periodontitis-induced glucose variability, insulin resistance, and gut microbiota dysbiosis in mice. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-18594-7
|
| 231 |
Rustu Turkay, Abdurrahman Fatih Aydin, Ilknur Bingul, Canan Kucukgergin, Isin Dogan-Ekici, Elif Hocaoglu, Ercan Inci, Baris Bakir, Mujdat Uysal. Can Ultrasound Imaging Predict the Success of an Experimental Steatofibrosis Model?. Ultrasound Quarterly 2017; 33(2) doi: 10.1097/RUQ.0000000000000286
|
| 232 |
Princy Khurana, Tulasi Yadati, Sandeep Goyal, Atul Dolas, Tom Houben, Yvonne Oligschlaeger, Anil Agarwal, Aditya Kulkarni, Ronit Shiri-Sverdlov. Inhibiting Extracellular Cathepsin D Reduces Hepatic Steatosis in Sprague–Dawley Rats. Biomolecules 2019; 9(5) doi: 10.3390/biom9050171
|
| 233 |
Mayuko Ichimura-Shimizu, Katsuhisa Omagari, Michiko Yamashita, Koichi Tsuneyama. Development of a novel mouse model of diet-induced nonalcoholic steatohepatitis–related progressive bridging fibrosis. Bioscience, Biotechnology, and Biochemistry 2021; 85(4) doi: 10.1093/bbb/zbaa107
|
| 234 |
Pablo Guillermo Hernández-Almonacid, Ximena Marín-Quintero. Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: Transforming diagnosis and therapeutic approaches. World Journal of Gastroenterology 2026; 32(2): 111737 doi: 10.3748/wjg.v32.i2.111737
|
| 235 |
Lucie Aumailley, Marie Julie Dubois, André Marette, Michel Lebel. Integrated liver and serum proteomics uncover sexual dimorphism and alteration of several immune response proteins in an aging Werner syndrome mouse model. Aging 2024; 16(10) doi: 10.18632/aging.205866
|
| 236 |
Madalina Andreea Robea, Ioana-Miruna Balmus, Irina Girleanu, Laura Huiban, Cristina Muzica, Alin Ciobica, Carol Stanciu, Carmen Diana Cimpoesu, Anca Trifan. Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance. Medicina 2023; 59(9) doi: 10.3390/medicina59091614
|
| 237 |
Hyun Joo Shin, Haesung Yoon, Myung-Joon Kim, Seok Joo Han, Hong Koh, Seung Kim, Mi-Jung Lee. Liver intravoxel incoherent motion diffusion-weighted imaging for the assessment of hepatic steatosis and fibrosis in children. World Journal of Gastroenterology 2018; 24(27): 3013-3020 doi: 10.3748/wjg.v24.i27.3013
|
| 238 |
Andrea Boitnott, Yuhui Hu, Mary Wight-Carter, Christian Lopez Escobar, Xin Chen, Steven J. Gray. DDX3X overexpression in mice can cause rapid tissue-specific toxicity and mortality. Molecular Therapy 2026; doi: 10.1016/j.ymthe.2026.07.032
|
| 239 |
Jieun Moon, Eunji Kong, Jingu Lee, Jinjoo Jung, Eunha Kim, Seung Bum Park, Pilhan Kim. Intravital longitudinal imaging of hepatic lipid droplet accumulation in a murine model for nonalcoholic fatty liver disease. Biomedical Optics Express 2020; 11(9) doi: 10.1364/BOE.395890
|
| 240 |
Kana Goto, Koudai Kani, Miyuna Kato, Naoya Igarashi, Yuki Tada, Kaichi Kasai, Mayuko Ichimura-Shimizu, Shiro Watanabe, Koichi Tsuneyama, Yukihiro Furusawa, Yoshinori Nagai. Critical Role of Cholic Acid in the Development of iHFC Diet-induced MASH in TSNO Mice. Inflammation 2025; 48(5) doi: 10.1007/s10753-025-02294-5
|
| 241 |
Luma Melo, Merve Bilici, Amit Hagar, James E. Klaunig. The effect of endurance training on non‐alcoholic fatty liver disease in mice. Physiological Reports 2021; 9(15) doi: 10.14814/phy2.14926
|
| 242 |
Md Asrarul Islam, Rhema Khairnar, Joshua Fleishman, Sandra E. Reznik, Louis Ragolia, Shruthi Gobbooru, Sunil Kumar. Female C57BL/6 mice exhibit protection against nonalcoholic fatty liver disease and diabesity accompanied by differential regulation of hepatic lipocalin prostaglandin D2 synthase. Molecular and Cellular Endocrinology 2025; 595 doi: 10.1016/j.mce.2024.112404
|
| 243 |
Mark Shapses, Lin Tang, Austin Layne, Andrea Beri, Yaron Rotman. Fatty Liver Is an Independent Risk Factor for Delayed Recovery from Anesthesia. Hepatology Communications 2021; 5(11) doi: 10.1002/hep4.1772
|
| 244 |
Georgios Tsamos, Dimitra Vasdeki, Theocharis Koufakis, Vassiliki Michou, Kali Makedou, Georgios Tzimagiorgis. Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes. Metabolites 2023; 13(4) doi: 10.3390/metabo13040517
|
| 245 |
Chin Xuan Tan, Gun Hean Chong, Hazilawati Hamzah, Hasanah Mohd Ghazali. Hypocholesterolaemic and hepatoprotective effects of virgin avocado oil in diet‐induced hypercholesterolaemia rats. International Journal of Food Science & Technology 2018; 53(12) doi: 10.1111/ijfs.13880
|
| 246 |
Pradipta Mukherjee, Shinichi Fukuda, Donny Lukmanto, Toshiharu Yamashita, Kosuke Okada, Shuichi Makita, Ibrahim Abd El-Sadek, Arata Miyazawa, Lida Zhu, Rion Morishita, Antonia Lichtenegger, Tetsuro Oshika, Yoshiaki Yasuno. Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography. Biomedical Optics Express 2022; 13(7) doi: 10.1364/BOE.461433
|
| 247 |
Eun Hye Lee, Ji Young Kim, Hye Ran Yang. Sex-specific differences in ectopic fat and metabolic characteristics of paediatric nonalcoholic fatty liver disease. International Journal of Obesity 2024; 48(4) doi: 10.1038/s41366-023-01439-6
|
| 248 |
Shahinul Alam, Mohammad Jahid Hasan, Md. Abdullah Saeed Khan, Mahabubul Alam, Nazmul Hasan. Effect of weight reduction on histological activity and fibrosis of lean nonalcoholic steatohepatitis patient. Journal of Translational Internal Medicine 2019; 7(3) doi: 10.2478/jtim-2019-0023
|
| 249 |
Triya Saha, Ayushi Mairal, Shreya Mehrotra, Shiv K. Sarin, Ashok Kumar. Bioengineered Exosome‐Loaded Immunomodulatory Bioadhesive Spray Reverses Liver Fibrosis and Metabolic Dysfunction That Triggers Beneficial Gut‐Liver Crosstalk in Chronic Fatty Liver Disease. Advanced Science 2026; doi: 10.1002/advs.76420
|
| 250 |
Junko Kuramoto, Eri Arai, Mao Fujimoto, Ying Tian, Yuriko Yamada, Takuya Yotani, Satomi Makiuchi, Noboru Tsuda, Hidenori Ojima, Moto Fukai, Yosuke Seki, Kazunori Kasama, Nobuaki Funahashi, Haruhide Udagawa, Takao Nammo, Kazuki Yasuda, Akinobu Taketomi, Tatsuya Kanto, Yae Kanai. Quantification of DNA methylation for carcinogenic risk estimation in patients with non-alcoholic steatohepatitis. Clinical Epigenetics 2022; 14(1) doi: 10.1186/s13148-022-01379-4
|
| 251 |
Christine Dominguez. NASH Syndrome. Gastroenterology Nursing 2018; 41(4) doi: 10.1097/SGA.0000000000000334
|
| 252 |
Tea Omanovic Kolaric, Tomislav Kizivat, Vjera Mihaljevic, Milorad Zjalic, Ines Bilic-Curcic, Lucija Kuna, Robert Smolic, Aleksandar Vcev, George Y. Wu, Martina Smolic. Liraglutide Exerts Protective Effects by Downregulation of PPARγ, ACSL1 and SREBP-1c in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis. Current Issues in Molecular Biology 2022; 44(8) doi: 10.3390/cimb44080239
|
| 253 |
Arinc Ozturk, Joseph R. Grajo, Michael S. Gee, Alex Benjamin, Rebecca E. Zubajlo, Kai E. Thomenius, Brian W. Anthony, Anthony E. Samir, Manish Dhyani. Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance. Ultrasound in Medicine & Biology 2018; 44(12) doi: 10.1016/j.ultrasmedbio.2018.07.019
|
| 254 |
Panadda Jako, Pennapa Chonpathompikunlert, Wachirawadee Malakul, Sakara Tunsophon. Passiflora edulis extract ameliorates HFD-induced hepatic steatosis mediated through Nrf2 and IRS-1 activation, NFκB suppression, and hepatic lipid metabolism and bile acid modulation in obese rats. Journal of Functional Foods 2024; 120 doi: 10.1016/j.jff.2024.106351
|
| 255 |
Naoto Kubota, Hidenori Ojima, Mami Hatano, Ken Yamazaki, Yohei Masugi, Hanako Tsujikawa, Yoko Fujii‐Nishimura, Akihisa Ueno, Yutaka Kurebayashi, Masahiro Shinoda, Minoru Kitago, Yuta Abe, Yuko Kitagawa, Michiie Sakamoto. Clinicopathological features of hepatocellular carcinoma with fatty change: Tumors with macrovesicular steatosis have better prognosis and aberrant expression patterns of perilipin and adipophilin. Pathology International 2020; 70(4) doi: 10.1111/pin.12889
|
| 256 |
Yu Tahara, Shigenobu Shibata. Circadian rhythms of liver physiology and disease: experimental and clinical evidence. Nature Reviews Gastroenterology & Hepatology 2016; 13(4) doi: 10.1038/nrgastro.2016.8
|
| 257 |
Desak Gede Budi Krisnamurti, Erni H. Purwaningsih, Tri Juli Edi Tarigan, Christian Marco Hadi Nugroho, Vivian Soetikno, Melva Louisa. Alterations of Liver Functions and Morphology in a Rat Model of Prediabetes After a Short-term Treatment of a High-fat High-glucose and Low-dose Streptozotocin. Open Access Macedonian Journal of Medical Sciences 2022; 10(A) doi: 10.3889/oamjms.2022.8717
|
| 258 |
Nelson Kei, Vincent Wai Sun Wong, Susana Lauw, Lijun You, Peter Chi Keung Cheung. Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD). Foods 2023; 12(17) doi: 10.3390/foods12173279
|
| 259 |
Manca Povsic, On Yee Wong, Richard Perry, Juliana Bottomley. A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH). Advances in Therapy 2019; 36(7) doi: 10.1007/s12325-019-00960-3
|
| 260 |
Emily J. Miller, Yongmei M. Jin, Jingfeng Jiang. Investigating confounding factors in shear wave speed measurements of fibrotic liver tissues: a computer simulation study. Physical and Engineering Sciences in Medicine 2026; 49(2) doi: 10.1007/s13246-026-01712-8
|
| 261 |
The Effect of Ethanol Extract Mymercodia pendans on Paracetamol-Induced Hepatotoxicity in White Rats. IOP Conference Series: Earth and Environmental Science 2019; 248 doi: 10.1088/1755-1315/248/1/012045
|
| 262 |
Patrick H. Sweet, Teresa Khoo, Steven Nguyen. Nonalcoholic Fatty Liver Disease. Primary Care: Clinics in Office Practice 2017; 44(4) doi: 10.1016/j.pop.2017.07.003
|
| 263 |
Chew W. Cheng, Lucia Pedicini, Cintli Morales Alcala, Fenia Deligianni, Jessica Smith, Ryan D. Murray, Harriet J. Todd, Niamh Forde, Lynn McKeown. RNA-seq analysis reveals transcriptome changes in livers from Efcab4b knockout mice. Biochemistry and Biophysics Reports 2025; 41 doi: 10.1016/j.bbrep.2025.101944
|
| 264 |
Joachim Worthington, Emily He, Georgia Carney, Paul Grogan, Megan Varlow, Karen Canfell, Eleonora Feletto. The potential for primary and secondary prevention of liver cancer death in Australians with alcohol-related liver disease or metabolic-associated steatotic liver disease: A modelling study. Public Health 2025; 243 doi: 10.1016/j.puhe.2025.03.030
|
| 265 |
Weicheng Sun, Ping Zhang, Jinsheng Xu, Weihan Zhang, Yongbin Zeng, Li Li. Bridging attention fusion-based multi-view graph neural networks for spatial gene expression prediction. Pattern Recognition 2026; 171 doi: 10.1016/j.patcog.2025.112207
|
| 266 |
M. ZAGOROVA, A. PRASNICKA, Z. KADOVA, E. DOLEZELOVA, L. KAZDOVA, J. CERMANOVA, L. ROZKYDALOVA, M. HROCH, J. MOKRY, S. MICUDA. Boldine Attenuates Cholestasis Associated With Nonalcoholic Fatty Liver Disease in Hereditary Hypertriglyceridemic Rats Fed by High-Sucrose Diet. Physiological Research 2015; doi: 10.33549/physiolres.933206
|
| 267 |
Milos Mihajlovic, Mathieu Vinken. Mitochondria as the Target of Hepatotoxicity and Drug-Induced Liver Injury: Molecular Mechanisms and Detection Methods. International Journal of Molecular Sciences 2022; 23(6) doi: 10.3390/ijms23063315
|
| 268 |
Nurina Hasanatuludhhiyah, Arifa Mustika, Viskasari Pintoko Kalanjati, Muhammad Miftahussurur, Hirokazu Wakuda, Naoto Uemura. Clinacanthus nutans leaf extract prevents metabolic dysfunction-associated steatotic liver (MASL) to metabolic dysfunction-associated steatohepatitis (MASH) progression in western diet-fed C57BL/6 mice. Pharmacia 2025; 72 doi: 10.3897/pharmacia.72.e162588
|
| 269 |
Zeynep Tuğba Dönmez Atılgan, Özlem Tok, Zeynep Göktaş. Metabolic dysfunction-associated steatotic liver disease in women with polycystic ovary syndrome and its relation with other concomitant factors. Mediterranean Journal of Nutrition and Metabolism 2026; 19(1) doi: 10.1177/1973798X251377712
|
| 270 |
Jie Yan, Yang Yu, Jeon Woong Kang, Zhi Yang Tam, Shuoyu Xu, Eliza Li Shan Fong, Surya Pratap Singh, Ziwei Song, Lisa Tucker‐Kellogg, Peter T. C. So, Hanry Yu. Development of a classification model for non‐alcoholic steatohepatitis (NASH) using confocal Raman micro‐spectroscopy. Journal of Biophotonics 2017; 10(12) doi: 10.1002/jbio.201600303
|
| 271 |
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali, Archana Burman. Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma. Journal of Cellular Biochemistry 2022; 123(10) doi: 10.1002/jcb.30252
|
| 272 |
Giuseppe Derosa, Pamela Maffioli. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016; doi: 10.1007/978-94-007-7742-2_23-1
|
| 273 |
Kaitlyn Purdie, Narain Karedla, Thea Guy, Anna V. Schepers, Ana Isabel Espirito Santo, Huw Colin-York, Kseniya Korobchevskaya, Helena Coker, Carl Lee, Alex Gordon-Weeks, Jagdeep Nanchahal, Marco Fritzsche. Metabolic profiling of steatotic liver disease by fluorescence lifetime imaging microscopy. Communications Medicine 2026; 6(1) doi: 10.1038/s43856-026-01605-7
|
| 274 |
Hieu Huy Phung, Chang Hoon Lee. Mouse models of nonalcoholic steatohepatitis and their application to new drug development. Archives of Pharmacal Research 2022; 45(11) doi: 10.1007/s12272-022-01410-5
|
| 275 |
Gordon P. Watt, Miryoung Lee, Jen-Jung Pan, Michael B. Fallon, Rohit Loomba, Laura Beretta, Joseph B. McCormick, Susan P. Fisher-Hoch. High Prevalence of Hepatic Fibrosis, Measured by Elastography, in a Population-Based Study of Mexican Americans. Clinical Gastroenterology and Hepatology 2019; 17(5) doi: 10.1016/j.cgh.2018.05.046
|
| 276 |
Gabriel Scarlat, Bassil Dona, Mihai Cârstea, Marilena Stoian. Insights into Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Internal Medicine 2022; 19(1) doi: 10.2478/inmed-2022-0198
|
| 277 |
Jinchao Hou, Jue Zhang, Ping Cui, Yingyue Zhou, Can Liu, Xiaoliang Wu, Yun Ji, Sicong Wang, Baoli Cheng, Hui Ye, Liqi Shu, Kai Zhang, Di Wang, Jielin Xu, Qiang Shu, Marco Colonna, Xiangming Fang. TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis. Journal of Clinical Investigation 2021; 131(4) doi: 10.1172/JCI135197
|
| 278 |
Yunfu Feng, Sijie Zheng, Luojie Liu, Yanting Yang. Association of serum uric acid with hepatic steatosis detected by controlled attenuation parameter in the United States population. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01846-8
|
| 279 |
Sung Rye Park, Chun-Seok Cho, Jingyue Xi, Hyun Min Kang, Jun Hee Lee. Holistic characterization of single-hepatocyte transcriptome responses to high-fat diet. American Journal of Physiology-Endocrinology and Metabolism 2021; 320(2) doi: 10.1152/ajpendo.00391.2020
|
| 280 |
Ji Soo Lee, Partha Mukhopadhyay, Csaba Matyas, Eszter Trojnar, Janos Paloczi, Yuan Ru Yang, Brandon A. Blank, Cody Savage, Alexander V. Sorokin, Nehal N. Mehta, Janaina C. M. Vendruscolo, George F. Koob, Leandro F. Vendruscolo, Pal Pacher, Falk W. Lohoff. PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53603-6
|
| 281 |
Albine Djeagou, Kavyasri Gunukula, Anas Sermani, Sai Kiran Vaspari. Emerging Perspectives in the Diagnosis and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Narrative Review. Cureus 2025; doi: 10.7759/cureus.95288
|
| 282 |
Eiad Janini, Bashar Fteiha, Imran Ramlawi, Mahmud Mahamid. Clinical Trajectory and Predictors of Intensive Care Unit Mortality Among Nonalcoholic Fatty Liver Disease Patients: A Retrospective Case–Control Study. Journal of Clinical and Experimental Hepatology 2023; 13(2) doi: 10.1016/j.jceh.2022.11.010
|
| 283 |
Ivana Cataldo, Samantha Sarcognato, Diana Sacchi, Matilde Cacciatore, Francesca Baciorri, Alessandra Mangia, Nora Cazzagon, Maria Guido. Pathology of non-alcoholic fatty liver disease. Pathologica 2021; 113(3) doi: 10.32074/1591-951X-242
|
| 284 |
Pan Li, Ruoyu Zhang, Pingping Hu, Tingting Wang, Jianwei Wang. Cepharanthine relieves nonalcoholic steatohepatitis through inhibiting STAT1/CXCL10 axis-mediated lipogenesis and inflammatory responses. Journal of Ethnopharmacology 2025; 341 doi: 10.1016/j.jep.2025.119358
|
| 285 |
Anđela Milićević, Nevena Lazović, Nada Tomanović. Pathohistological characteristics of steatohepatitis on needle biopsy sample from 100 patients. Medicinski podmladak 2019; 70(1) doi: 10.5937/mp70-18029
|
| 286 |
Emine Turkmen Samdanci. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.99842
|
| 287 |
Byung-Kwan Jeong, Won-Il Choi, Wonsuk Choi, Jieun Moon, Won Hee Lee, Chan Choi, In Young Choi, Sang-Hyun Lee, Jung Kuk Kim, Young Seok Ju, Pilhan Kim, Young-Ah Moon, Jun Yong Park, Hail Kim. A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-50660-y
|
| 288 |
Maria Nicoline Baandrup Kristiansen, Sanne Skovgård Veidal, Christina Christoffersen, Michael Feigh, Niels Vrang, Jonathan David Roth, Mary Erickson, Luciano Adorini, Jacob Jelsing. Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1149-z
|
| 289 |
Hala Saeed Jaara, Sandra Torres. Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases. Exploration of Digestive Diseases 2024; 3(6) doi: 10.37349/edd.2024.00062
|
| 290 |
Yusuf Yilmaz, Fatih Eren. Serum biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic fatty liver disease: association with liver histology. European Journal of Gastroenterology & Hepatology 2019; 31(1) doi: 10.1097/MEG.0000000000001240
|
| 291 |
Monique Fernandez, Julie Lokan, Christopher Leung, Andrew Grigg. A critical evaluation of the role of iron overload in fatty liver disease. Journal of Gastroenterology and Hepatology 2022; 37(10) doi: 10.1111/jgh.15971
|
| 292 |
Humanized mouse liver reveals endothelial control of essential hepatic metabolic functions. Cell 2023; 186(18) doi: 10.1016/j.cell.2023.07.017
|
| 293 |
Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Balteanu, Ramona Cioboata, Alice Elena Ghenea, Suzana Danoiu, Ana-Maria Bumbea, Viorel Biciusca. The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review. Diagnostics 2023; 13(21) doi: 10.3390/diagnostics13213316
|
| 294 |
Hossam Magdy Balaha, Khadiga M. Ali, Ali Mahmoud, Ahmed Aboudessouki, Mohamed T. Azam, Guruprasad A. Giridharan, Dibson Gondim, Ayman El-Baz. From Hematoxylin and Eosin to Masson’s Trichrome: A Comprehensive Framework for Virtual Stain Transformation in Chronic Liver Disease Diagnosis. Diagnostics 2026; 16(5) doi: 10.3390/diagnostics16050764
|
| 295 |
Beibei Liu, Xiaoling Deng, Qianqian Jiang, Guixin Li, Junli Zhang, Ning Zhang, Shengliang Xin, Keshu Xu. Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4/NF-κB signaling pathway in mice. International Immunopharmacology 2019; 75 doi: 10.1016/j.intimp.2019.105797
|
| 296 |
Zhiqiang Jiang, Lili Yang, Qinxin Liu, Meiyue Qiu, Yu Chen, Mengying Teng, Yubin Zhang, Xing Liu, Zhonghua Zhao, Yuxin Zheng, Melvin Andersen, Weidong Qu. Haloacetamides exacerbate non-alcoholic fatty liver disease induced by a high-fat diet in C57BL/6J mice. Toxicological Sciences 2025; 204(1) doi: 10.1093/toxsci/kfae160
|
| 297 |
Md.N. Bari, Md. Anwar, Md.R. Ansari, E.H.A. Osman, M.A. Alfaki, I. Mohammad. A complicated situation of diagnosis of biomarkers in alcoholic liver cirhosis injury by roussel uclaf causality assessment method. THE NEW ARMENIAN MEDICAL JOURNAL 2025; 19(3) doi: 10.56936/18290825-3.19v.2025-23
|
| 298 |
Noha M. Hany, Sanaa Eissa, Manal Basyouni, Amany H. Hasanin, Yasmin M. Aboul-Ela, Nagwa M. Abo Elmagd, Iman F. Montasser, Mahmoud A. Ali, Paul J. Skipp, Marwa Matboli. Modulation of hepatic stellate cells by Mutaflor® probiotic in non-alcoholic fatty liver disease management. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03543-z
|
| 299 |
Mario D’Ambrosio, Elisabetta Bigagli, Lorenzo Cinci, Manuela Gencarelli, Sofia Chioccioli, Natascia Biondi, Liliana Rodolfi, Alberto Niccolai, Francesca Zambelli, Annunziatina Laurino, Laura Raimondi, Mario R. Tredici, Cristina Luceri. Tisochrysis lutea F&M-M36 Mitigates Risk Factors of Metabolic Syndrome and Promotes Visceral Fat Browning through β3-Adrenergic Receptor/UCP1 Signaling. Marine Drugs 2023; 21(5) doi: 10.3390/md21050303
|
| 300 |
Ravi Adinarayan Somabattini, Sahla Sherin, Bhukya Siva, Neelanjan Chowdhury, Satheesh Kumar Nanjappan. Unravelling the complexities of non-alcoholic steatohepatitis: The role of metabolism, transporters, and herb-drug interactions. Life Sciences 2024; 351 doi: 10.1016/j.lfs.2024.122806
|
| 301 |
Hyunghee Lee, Jiwon Ahn, Soon Shik Shin, Michung Yoon. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice. International Journal of Obesity 2019; 43(8) doi: 10.1038/s41366-018-0212-0
|
| 302 |
Olga Estévez-Vázquez, Raquel Benedé-Ubieto, Feifei Guo, Beatriz Gómez-Santos, Patricia Aspichueta, Johanna Reissing, Tony Bruns, Carlos Sanz-García, Svenja Sydor, Lars P. Bechmann, Eva Maranillo, José Ramón Sañudo, María Teresa Vázquez, Arantza Lamas-Paz, Laura Morán, Marina S. Mazariegos, Andreea Ciudin, Juan M. Pericàs, María Isabel Peligros, Javier Vaquero, Eduardo Martínez-Naves, Christian Liedtke, José R. Regueiro, Christian Trautwein, Rafael Bañares, Francisco Javier Cubero, Yulia A. Nevzorova. Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD). Biomedicines 2021; 9(10) doi: 10.3390/biomedicines9101289
|
| 303 |
Ganka Bekyarova, Maria Tzaneva, Kamelia Bratoeva, Irina Ivanova, Andrei Kotzev, Minka Hristova, Dimo Krastev, Ivan Kindekov, Milka Mileva. 4-Hydroxynonenal (HNE) and hepatic injury related to chronic oxidative stress. Biotechnology & Biotechnological Equipment 2019; 33(1) doi: 10.1080/13102818.2019.1674690
|
| 304 |
Shunming Zhang, Xiaohui Wu, Shanshan Bian, Qing Zhang, Li Liu, Ge Meng, Zhanxin Yao, Hongmei Wu, Yeqing Gu, Yawen Wang, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Kaijun Niu. Association between consumption frequency of honey and non-alcoholic fatty liver disease: results from a cross-sectional analysis based on the Tianjin Chronic Low-grade Systemic Inflammation and Health (TCLSIH) Cohort Study. British Journal of Nutrition 2021; 125(6) doi: 10.1017/S0007114520003190
|
| 305 |
Kaichi Kasai, Naoya Igarashi, Yuki Tada, Koudai Kani, Shun Takano, Tsutomu Yanagibashi, Fumitake Usui-Kawanishi, Shiho Fujisaka, Shiro Watanabe, Mayuko Ichimura-Shimizu, Kiyoshi Takatsu, Kazuyuki Tobe, Koichi Tsuneyama, Yukihiro Furusawa, Yoshinori Nagai. Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice. International Journal of Molecular Sciences 2023; 24(4) doi: 10.3390/ijms24044050
|
| 306 |
Meryem Altin Karagoz, Bahriye Akay, Alper Basturk, Dervis Karaboga, O. Ufuk Nalbantoglu. An unsupervised transfer learning model based on convolutional auto encoder for non-alcoholic steatohepatitis activity scoring and fibrosis staging of liver histopathological images. Neural Computing and Applications 2023; 35(14) doi: 10.1007/s00521-023-08252-2
|
| 307 |
Noor Syafiqa Aqila Mohd Rosmi, Nurul Husna Shafie, Azrina Azlan, Maizaton Atmadini Abdullah. Functional food mixtures: Inhibition of lipid peroxidation, HMGCoA reductase, and ACAT2 in hypercholesterolemia‐induced rats. Food Science & Nutrition 2021; 9(2) doi: 10.1002/fsn3.2051
|
| 308 |
Yuki Tada, Kaichi Kasai, Nana Makiuchi, Naoya Igarashi, Koudai Kani, Shun Takano, Hiroe Honda, Tsutomu Yanagibashi, Yasuharu Watanabe, Fumitake Usui-Kawanishi, Yukihiro Furusawa, Mayuko Ichimura-Shimizu, Yoshiaki Tabuchi, Kiyoshi Takatsu, Koichi Tsuneyama, Yoshinori Nagai. Roles of Macrophages in Advanced Liver Fibrosis, Identified Using a Newly Established Mouse Model of Diet-Induced Non-Alcoholic Steatohepatitis. International Journal of Molecular Sciences 2022; 23(21) doi: 10.3390/ijms232113251
|
| 309 |
Mohammad Y. Alshahrani, Fahad S. Al Amri, Nervana M. Bayoumy, Muath Suliman, Basma E. Aboulhoda, Hend Abdallah, Walaa Ibrahim, Heba Elwi, Alia Albawardi, Bahjat Al-Ani, Hend Ashour, Norah M. Alzamil. Suppression of non-alcoholic fatty liver disease by thymoquinone associated with inhibition of miRNA-155/ROS/p53/TIMP-1-mediated fibrosis and autophagy upregulation. Turkish Journal of Biochemistry 2026; 51(1) doi: 10.1515/tjb-2025-0102
|
| 310 |
Yun Ji, Yuan Gao, Hong Chen, Yue Yin, Weizhen Zhang. Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress. Nutrients 2019; 11(9) doi: 10.3390/nu11092062
|
| 311 |
Jasmine Harumi Sabini, Kris Herawan Timotius. Hepatoprotective and Fat-Accumulation-Reductive Effects of Curcumin on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Current Issues in Molecular Biology 2025; 47(3) doi: 10.3390/cimb47030159
|
| 312 |
Zheng Liu, Changyu Zhang, Zipeng Li, Wanying Ma, Jia Liu, Xiang Xia, Ning Xu, Wen Sun, Jianjun Du, Jiangli Fan, Xiaojun Peng. Visualization of the protective role of estrogen against female liver fibrosis via an ER viscosity NIR fluorescent probe. Science China Chemistry 2025; 68(1) doi: 10.1007/s11426-024-2061-7
|
| 313 |
Chong Yin, Siqi Liu, Fei Lyu, Jiahao Lu, Sune Darkner, Vincent Wai-Sun Wong, Pong C. Yuen. XFibrosis: Explicit Vessel-Fiber Modeling for Fibrosis Staging from Liver Pathology Images. 2024 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) 2024; doi: 10.1109/CVPR52733.2024.01072
|
| 314 |
Yaojie Fu, Luca Maccioni, Xin Wei Wang, Tim F. Greten, Bin Gao. Alcohol-associated liver cancer. Hepatology 2024; 80(6) doi: 10.1097/HEP.0000000000000890
|
| 315 |
Neil B. Blok, Andriy Myronovych, Garrett McMahon, Nadejda Bozadjieva-Kramer, Randy J. Seeley. The evolution of steatosis and fibrosis in mice on a MASH-inducing diet and the effects of housing temperature. American Journal of Physiology-Endocrinology and Metabolism 2025; 328(4) doi: 10.1152/ajpendo.00401.2024
|
| 316 |
Liangyu Hu, Huarong Du, QianQian Zhou, Chunlei Liu, Tiansong Zhang, Min Yuan. Web of Science‐Based Visualization of Metabolic Dysfunction‐Associated Fatty Liver Disease in Pediatric and Adolescent Populations: A Bibliometric Study. Health Science Reports 2025; 8(2) doi: 10.1002/hsr2.70409
|
| 317 |
S. Young, M. Rivard, R. Kimyon, T. Sanghvi. Accuracy of liver ablation zone prediction in a single 2450MHz 100 Watt generator model microwave ablation system: An in human study. Diagnostic and Interventional Imaging 2020; 101(4) doi: 10.1016/j.diii.2019.10.007
|
| 318 |
Christophe Regnault, Marie Usal, Sylvie Veyrenc, Karine Couturier, Cécile Batandier, Anne-Laure Bulteau, David Lejon, Alexandre Sapin, Bruno Combourieu, Maud Chetiveaux, Cédric Le May, Thomas Lafond, Muriel Raveton, Stéphane Reynaud.
Unexpected metabolic disorders induced by endocrine disruptors in
Xenopus tropicalis
provide new lead for understanding amphibian decline
. Proceedings of the National Academy of Sciences 2018; 115(19) doi: 10.1073/pnas.1721267115
|
| 319 |
Tommaso Dionisi, Linda Galasso, Luigiandrea Antuofermo, Francesco Antonio Mancarella, Giorgio Esposto, Irene Mignini, Maria Elena Ainora, Antonio Gasbarrini, Giovanni Addolorato, Maria Assunta Zocco. Shear Wave Dispersion Elastography in ALD and MASLD: Comparative Pathophysiology and Clinical Potential—A Narrative Review. Journal of Clinical Medicine 2024; 13(24) doi: 10.3390/jcm13247799
|
| 320 |
Soo Hyun Kim, Gyuri Kim, Dai Hoon Han, Milim Lee, Irene Kim, Bohkyung Kim, Kook Hwan Kim, Young-Mi Song, Jeong Eun Yoo, Hye Jin Wang, Soo Han Bae, Yong-Ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Myung-Shik Lee. Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition. Autophagy 2017; 13(10) doi: 10.1080/15548627.2017.1356977
|
| 321 |
Hui Zhou, Bin Niu, Xue Wu, Weike Chu, Yibing Zhou, Ze Chen, Yuqiang Mi, Yonggang Liu, Ping Li. iTRAQ-based quantitative proteomics analysis of the effect of ACT001 on non-alcoholic steatohepatitis in mice. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-38448-4
|
| 322 |
Deogade Sakshi Rajeshwar, Sree Vaishnavi Nalla, Itishree Dubey, Rohit Kumar Gautam, Shivani Bhardwaj, Richa Shrivastava, Sapana Kushwaha. Arsenic Exposure Alters Liver Metabolism and Accelerates Skeletal Muscle Atrophy in Female BALB/c Mice. Biological Trace Element Research 2025; 204(4) doi: 10.1007/s12011-025-04839-z
|
| 323 |
Maria N. B. Kristiansen, Sanne S. Veidal, Christina Christoffersen, Jacob Jelsing, Kristoffer T. G. Rigbolt. Molecular Characterization of Microvesicular and Macrovesicular Steatosis Shows Widespread Differences in Metabolic Pathways. Lipids 2019; 54(1) doi: 10.1002/lipd.12121
|
| 324 |
Kirthika Venkatesan, Nisha Nigil Haroon. Management of Metabolic-Associated Fatty Liver Disease. Endocrinology and Metabolism Clinics of North America 2023; 52(3) doi: 10.1016/j.ecl.2023.02.002
|
| 325 |
Zhuhuang Zhou, Jui Fang, Anca Cristea, Ying-Hsiu Lin, Yu-Wei Tsai, Yung-Liang Wan, Kee-Min Yeow, Ming-Chih Ho, Po-Hsiang Tsui. Value of homodyned K distribution in ultrasound parametric imaging of hepatic steatosis: An animal study. Ultrasonics 2020; 101 doi: 10.1016/j.ultras.2019.106001
|
| 326 |
Inmaculada Fernandez-Canadas, Alejandro Badajoz, Jesús Jimenez-Gonzalez, Martin Wirenfeldt, Beatriz Paniagua-Torija, Clara Bravo-Jimenez, Mar Del Cerro, Angel Arevalo-Martin, Daniel Garcia-Ovejero. Spinal cord injury induces transient activation of hepatic stellate cells in rat liver. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-87131-3
|
| 327 |
Mahmud Mahamid, Naim Mahroum, Nicola Bragazzi, Kasem Shalaata, Yarden Yavne, Mohammad Adawi, Howard Amital, Abdulla Watad. Folate and B12 Levels Correlate with Histological Severity in NASH Patients. Nutrients 2018; 10(4) doi: 10.3390/nu10040440
|
| 328 |
M. Vanessa Bullón-Vela, Itziar Abete, J. Alfredo Martínez, M. Angeles Zulet. Obesity. 2018; doi: 10.1016/B978-0-12-812504-5.00006-4
|
| 329 |
Xueyan Lv, Dianchao Mi Mi, Yuhang Xin, Wei Dong, Dongmei Wang. Sodium-Glucose Transport Protein-2 Inhibitors in the Treatment of Non-alcoholic Steatohepatitis: An Evidence-Based Review. Hepatitis Monthly 2025; 25(1) doi: 10.5812/hepatmon-153404
|
| 330 |
Laura Taban, Dana Stoian, Bogdan Timar, Daniela Amzar, Calin Adela, Alexandru Motofelea, Andreea Borlea, Romain Frisoni, Nadege Laguerre. Vitamin D Status and Steatohepatitis in Obese Diabetic and Non-Diabetic Patients. Journal of Clinical Medicine 2022; 11(18) doi: 10.3390/jcm11185482
|
| 331 |
Dahae Lee, Tuy An Trinh, Myoung-Sook Shin, Ki Sung Kang. Recent Advancements in Microbial Diversity. 2022; doi: 10.1016/B978-0-12-822368-0.00009-8
|
| 332 |
Vesna Brzački, Andriana Jovanović, Andrija Rančić, Snežana Tešić-Rajković, Gordana Petrović, Ivan Nagorni, Marko Stojanović, Elena Stanković, Stefan Momčilović. Circulating and Tissue Galectin-3 in Gastrointestinal Inflammation: Clinical Significance and Biomarker Potential. Cells 2025; 14(19) doi: 10.3390/cells14191521
|
| 333 |
Doaa Abdelmoneim, Mohamed El‐Adl, Gehad El‐Sayed, El Said El‐Sherbini. Protective effect of fenofibrate against high‐fat–high‐fructose diet induced non‐obese NAFLD in rats. Fundamental & Clinical Pharmacology 2021; 35(2) doi: 10.1111/fcp.12597
|
| 334 |
Efstathia-Danai Bikouli, Rozeta Sokou, Monica Piras, Abraham Pouliakis, Eleftheria Karampela, Styliani Paliatsiou, Paraskevi Volaki, Gavino Faa, Theodoros Xanthos, Christos Salakos, Nicoletta M. Iacovidou. Study of Ovarian Damage in Piglets in an Experimental Model of Neonatal Asphyxia. Children 2025; 12(3) doi: 10.3390/children12030371
|
| 335 |
Denise Bonente, Sara Gargiulo, Ludovica Livi, Matteo Gramanzini, Tiziana Tamborrino, Lisa Gherardini, Giovanni Inzalaco, Lorenzo Franci, Mario Chiariello, Virginia Barone. Human-Mouse Convergence in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mouse Model Selection and Non-Invasive Diagnostic Strategies. Livers 2026; 6(3) doi: 10.3390/livers6030046
|
| 336 |
Yahya Pasdar, Farhad Oubari, Mahin Nikougoftar Zarif, Mehrnaz Abbasi, Azizollah Pourmahmoudi, Mahboobe Hosseinikia. Effects of Quercetin Supplementation on Hematological Parameters in Non-Alcoholic Fatty Liver Disease: a Randomized, Double-Blind, Placebo-Controlled Pilot Study. Clinical Nutrition Research 2020; 9(1) doi: 10.7762/cnr.2020.9.1.11
|
| 337 |
Daiane T. Oliveira, Adriano B. Chaves-Filho, Marcos Y. Yoshinaga, Nívia Carolina N. Paiva, Cláudia M. Carneiro, Sayuri Miyamoto, William T. Festuccia, Renata Guerra-Sá. Liver lipidome signature and metabolic pathways in nonalcoholic fatty liver disease induced by a high-sugar diet. The Journal of Nutritional Biochemistry 2021; 87 doi: 10.1016/j.jnutbio.2020.108519
|
| 338 |
Walaa Abdelhamed, Mohamed Elbadry, Mohamed El-Kassas. Evolving B-mode ultrasound-based techniques for assessing metabolic dysfunction-associated steatotic liver disease: Now and beyond. Liver Research 2026; 10(2) doi: 10.1016/j.livres.2026.05.001
|
| 339 |
Csaba Adori, Teresa Daraio, Raoul Kuiper, Swapnali Barde, Lubica Horvathova, Takashi Yoshitake, Robert Ihnatko, Ismael Valladolid-Acebes, Pauline Vercruysse, Ashley M. Wellendorf, Roberto Gramignoli, Bela Bozoky, Jan Kehr, Elvar Theodorsson, Jose A. Cancelas, Boris Mravec, Carl Jorns, Ewa Ellis, Jan Mulder, Mathias Uhlén, Christina Bark, Tomas Hökfelt. Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging. Science Advances 2021; 7(30) doi: 10.1126/sciadv.abg5733
|
| 340 |
Yuping Wang, Zhichao Liu, Wen Zou, Huixiao Hong, Hong Fang, Weida Tong. Molecular Regulation of Mirnas and Potential Biomarkers in the Progression of Hepatic Steatosis to NASH. Biomarkers in Medicine 2015; 9(11) doi: 10.2217/bmm.15.70
|
| 341 |
Monika Kubacka, Barbara Nowak, Monika Zadrożna, Małgorzata Szafarz, Gniewomir Latacz, Henryk Marona, Jacek Sapa, Szczepan Mogilski, Marek Bednarski, Magdalena Kotańska. Manifestations of Liver Impairment and the Effects of MH-76, a Non-Quinazoline α1-Adrenoceptor Antagonist, and Prazosin on Liver Tissue in Fructose-Induced Metabolic Syndrome. Metabolites 2023; 13(11) doi: 10.3390/metabo13111130
|
| 342 |
Snizhana V. Feysa, Svitlana O. Rudakova. INFLUENCE OF COMPLEX TREATMENT ON BIOCHEMICAL BLOOD PARAMETERS OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND CONCOMITANT PRE-DIABETES. Wiadomości Lekarskie 2021; 74(4) doi: 10.36740/WLek202104133
|
| 343 |
Chong Yin, Siqi Liu, Rui Shao, Pong C. Yuen. Medical Image Computing and Computer Assisted Intervention – MICCAI 2021. Lecture Notes in Computer Science 2021; 12905 doi: 10.1007/978-3-030-87240-3_15
|
| 344 |
David Hakimian, Johnny Amer, Alaa Jammal, Asher Shafrir, Yael Milgrom, Mohammad Masarowah, Wadi Hazou, Yuval Ishay, Ashraf Imam, Adi Francis, Abed Khalaileh, Rifaat Safadi. Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis. Vaccine: X 2023; 15 doi: 10.1016/j.jvacx.2023.100359
|
| 345 |
Sophie Cazanave, Alexei Podtelezhnikov, Kristian Jensen, Mulugeta Seneshaw, Divya P. Kumar, Hae-Ki Min, Prasanna K. Santhekadur, Bubu Banini, Adolfo Gabriele Mauro, Abdul M. Oseini, Robert Vincent, Keith Q. Tanis, Andrea L. Webber, Liangsu Wang, Pierre Bedossa, Faridoddin Mirshahi, Arun J. Sanyal. The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-17370-6
|
| 346 |
Shuai Li, Hui Yang, Wenjun Zhou, Ruoting Wang, Likang Li, Changfa Zhang, Jingyi Zhang, Yingxin Liu, Zhi Huang, Guowei Li, Mirella Giovarelli. Selenium Nanoparticles Decorated With Stevioside Potentially Attenuate Fructose Palmitate Induced Lipid Accumulation in HepG2 Cells. Mediators of Inflammation 2025; 2025(1) doi: 10.1155/mi/7942947
|
| 347 |
Hanaa Reyad Abdallah, Eman Refaat Youness, Manar Maher Bedeir, Marwa W. Abouelnaga, Wafaa M. Ezzat, Yasser Elhosary, Hazem Mohamed El-Hariri, Mona Abd Elmotaleb A. Hussein, Heba R. Ahmed, Rasha Eladawy. Clinical and diagnostic characteristics of non-alcoholic fatty liver disease among Egyptian children and adolescents with type1 diabetes. Diabetology & Metabolic Syndrome 2023; 15(1) doi: 10.1186/s13098-023-01029-6
|
| 348 |
Monika Adori, Sadam Bhat, Roberto Gramignoli, Ismael Valladolid-Acebes, Tore Bengtsson, Mathias Uhlèn, Csaba Adori. Hepatic Innervations and Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease 2023; 43(02) doi: 10.1055/s-0043-57237
|
| 349 |
Osama Hamid, Ahmed Eltelbany, Abdul Mohammed, Khaled Alsabbagh Alchirazi, Sushrut Trakroo, Imad Asaad. The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study. Annals of Hepatology 2022; 27(5) doi: 10.1016/j.aohep.2022.100727
|
| 350 |
Jialiu Zeng, Rebeca Acin-Perez, Essam A. Assali, Andrew Martin, Alexandra J. Brownstein, Anton Petcherski, Lucía Fernández-del-Rio, Ruiqing Xiao, Chih Hung Lo, Michaël Shum, Marc Liesa, Xue Han, Orian S. Shirihai, Mark W. Grinstaff. Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-38165-6
|
| 351 |
Qing-Yang Xu, Han Li, Hai-Xia Cao, Qin Pan, Jian-Gao Fan, Zhanjun Jia. APOC3 rs2070667 Associates with Serum Triglyceride Profile and Hepatic Inflammation in Nonalcoholic Fatty Liver Disease. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/8869674
|
| 352 |
Josiah E. Hardesty, Banrida Wahlang, Russell A. Prough, Kim Z. Head, Daniel Wilkey, Michael Merchant, Hongxue Shi, Jian Jin, Matthew C. Cave. Effect of Epidermal Growth Factor Treatment and Polychlorinated Biphenyl Exposure in a Dietary-Exposure Mouse Model of Steatohepatitis. Environmental Health Perspectives 2021; 129(3) doi: 10.1289/EHP8222
|
| 353 |
Ruri Yamaguchi, Tetsuro Oda, Kengo Nagashima. Comparison of the diagnostic accuracy of shear wave elastography with transient elastography in adult nonalcoholic fatty liver disease: a systematic review and network meta-analysis of diagnostic test accuracy. Abdominal Radiology 2024; 50(2) doi: 10.1007/s00261-024-04546-8
|
| 354 |
Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato. Basic Protocols in Foods and Nutrition. Methods and Protocols in Food Science 2022; doi: 10.1007/978-1-0716-2345-9_4
|
| 355 |
Si-Yi Lei, Yu Han, Don C. Rockey, Khalid Alswat, Vincent Wai-Sun Wong, Nozim Jumaev, Carlos Jesus Toro-Huamanchumo, Safwan Taha, Mohamed El-Kassas, Jacob George, Mark Muthiah, Omar Ghanem, Masato Yoneda, Dao Viet Hang, Giada Sebastiani, George Papatheodoridis, Adam Abu-Abeid, Andrew G. Robertson, Sang Hyun Kim, Rudolf Weiner, Kamal Mahawar, Asim Shabbir, Mohammad Kermansaravi, Reynu Rajan, Yosuke Seki, Halit Eren Taskin, Scott Shikora, Edward Oliveros, Chetan Parmar, Qiuye Cheng, Omar Thaher, Elena Ruiz-Úcar, Rodolfo Oviedo, Rui Ribeiro, Mario Musella, Almino C. Ramos, Seung-wan Ryu, Tamer Abdelbaki, Wei Jei Lee, Man Pan Chan, Jose Eduardo Garcia Flores, James Skinovsky, Ahmad Madkhali, Sylvia Weiner, Frank Tacke, Wah Yang, James Neuberger, Ming-Hua Zheng. An international multidisciplinary consensus statement on laparoscopic liver biopsy. Cell Reports Medicine 2026; 7(6) doi: 10.1016/j.xcrm.2026.102831
|
| 356 |
Maxime Barat, Thi Thuy Linh Nguyen, Clémence Hollande, Jean-Baptiste Coty, Christine Hoeffel, Benoit Terris, Anthony Dohan, Vincent Mallet, Stanislas Pol, Philippe Soyer. LI-RADS v2018 major criteria: Do hepatocellular carcinomas in non-alcoholic steatohepatitis differ from those in virus-induced chronic liver disease on MRI?. European Journal of Radiology 2021; 138 doi: 10.1016/j.ejrad.2021.109651
|
| 357 |
Yana Geng, Robert F. Schwabe. Hepatic stellate cell heterogeneity: Functional aspects and therapeutic implications. Hepatology 2025; doi: 10.1097/HEP.0000000000001386
|
| 358 |
Daye Mun, Sangdon Ryu, Daniel Junpyo Lee, Min-Jin Kwak, Hyejin Choi, An Na Kang, Dong-Hyun Lim, Sangnam Oh, Younghoon Kim. Bovine colostrum-derived extracellular vesicles protect against non-alcoholic steatohepatitis by modulating gut microbiota and enhancing gut barrier function. Current Research in Food Science 2025; 10 doi: 10.1016/j.crfs.2025.101039
|
| 359 |
Mehnoosh Torkzaban, Corinne E. Wessner, Dina Halegoua-DeMarzio, Andrej Lyshchik, Kibo Nam. Diagnostic Performance of Quantitative Ultrasound Parameters in Non-alcoholic Fatty Liver Disease. Academic Radiology 2024; 31(1) doi: 10.1016/j.acra.2023.07.001
|
| 360 |
Janna C. Nawroth, Debora B. Petropolis, Dimitris V. Manatakis, Tengku Ibrahim Maulana, Gabriel Burchett, Katharina Schlünder, Anke Witt, Abhishek Shukla, Konstantia Kodella, Janey Ronxhi, Gauri Kulkarni, Geraldine Hamilton, Ekihiro Seki, Shelly Lu, Katia C. Karalis. Modeling alcohol-associated liver disease in a human Liver-Chip. Cell Reports 2021; 36(3) doi: 10.1016/j.celrep.2021.109393
|
| 361 |
P. Mik, Z. Tonar, A. Malečková, L. Eberlová, V. Liška, R. Pálek, J. Rosendorf, M. Jiřík, H. Mírka, M. Králíčková, K. Witter. Distribution of Connective Tissue in the Male and Female Porcine Liver: Histological Mapping and Recommendations for Sampling. Journal of Comparative Pathology 2018; 162 doi: 10.1016/j.jcpa.2018.05.004
|
| 362 |
Zhenyu Wang, Maomao Zeng, Zhaojun Wang, Fang Qin, Jie Chen, Zhiyong He. Dietary Polyphenols to Combat Nonalcoholic Fatty Liver Disease via the Gut–Brain–Liver Axis: A Review of Possible Mechanisms. Journal of Agricultural and Food Chemistry 2021; 69(12) doi: 10.1021/acs.jafc.1c00751
|
| 363 |
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD). Journal of Clinical and Experimental Hepatology 2023; 13(2) doi: 10.1016/j.jceh.2022.11.014
|
| 364 |
G. Duwe, S. Knitter, S. Pesthy, A.S. Beierle, M. Bahra, M. Schmelzle, R.B. Schmuck, P. Lohneis, N. Raschzok, R. Öllinger, M. Sinn, B. Struecker, I.M. Sauer, J. Pratschke, A. Andreou. Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection. European Journal of Surgical Oncology 2017; 43(9) doi: 10.1016/j.ejso.2017.05.008
|
| 365 |
Rishit Gupta, Amit Nagora, Phidakordor Sahshong, Parth Parekh, Apurba Chakraborty, Manish Bhatt. Deep Parenchymal Steatosis Assessment and Quantification in Histopathology. IEEE Access 2025; 13 doi: 10.1109/ACCESS.2025.3615832
|
| 366 |
Qihao Zhang, Xianfu Luo, Liangdong Zhou, Thanh D. Nguyen, Martin R. Prince, Pascal Spincemaille, Yi Wang. Fluid Mechanics Approach to Perfusion Quantification: Vasculature Computational Fluid Dynamics Simulation, Quantitative Transport Mapping (QTM) Analysis of Dynamics Contrast Enhanced MRI, and Application in Nonalcoholic Fatty Liver Disease Classification. IEEE Transactions on Biomedical Engineering 2023; 70(3) doi: 10.1109/TBME.2022.3207057
|
| 367 |
Minjung Han, Seogsong Jeong, Jihun Song, Sun Jae Park, Cheol Min Lee, Kiheon Lee, Sang Min Park. Association between the dual use of electronic and
conventional cigarettes and NAFLD status in Korean men. Tobacco Induced Diseases 2023; 21(February) doi: 10.18332/tid/159167
|
| 368 |
Adrien Rohfritsch, Emilie Franceschini, Aurélien Dupré, David Melodelima. Quantitative ultrasound techniques for assessing thermal ablation: Measurement of the backscatter coefficient from ex vivo human liver. Medical Physics 2023; 50(11) doi: 10.1002/mp.16762
|
| 369 |
R.B. Prussick, L. Miele. Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?. British Journal of Dermatology 2018; 179(1) doi: 10.1111/bjd.16239
|
| 370 |
Joanna Mikołajczyk-Stecyna, Ewelina Zuk, Agata Chmurzynska, Malgorzata Blatkiewicz, Karol Jopek, Marcin Rucinski. Exposure to a choline-deficient diet during pregnancy and lactation alters the liver transcriptome profile in offspring of dams with fatty liver. Clinical Nutrition ESPEN 2025; 66 doi: 10.1016/j.clnesp.2025.01.028
|
| 371 |
Pippa J. Gunn, Camilla Pramfalk, Val Millar, Thomas Cornfield, Matthew Hutchinson, Elspeth M. Johnson, Shilpa R. Nagarajan, Perla Troncoso‐Rey, Richard F. Mithen, Katherine E. Pinnick, Maria H. Traka, Charlotte J. Green, Leanne Hodson. Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis. Physiological Reports 2020; 8(13) doi: 10.14814/phy2.14482
|
| 372 |
Yongzhi Zeng, Zhi Zheng, Fengtao Liu, Guanghui Yi. Circular RNAs in metabolism and metabolic disorders. Obesity Reviews 2021; 22(7) doi: 10.1111/obr.13220
|
| 373 |
Yang Yu, Jeon Woong Kang, Zhi Yang Tam, Shuo Yu Xu, Eliza Li Shan Fong, Surya Pratap Singh, Ziwei Song, Lisa Tucker Kellogg, Peter So, Hanry Yu, Jie Yan, J. Quincy Brown, Ton G. van Leeuwen. A classification model for non-alcoholic steatohepatitis (NASH) using confocal Raman micro-spectroscopy. Clinical and Preclinical Optical Diagnostics 2017; doi: 10.1117/12.2281445
|
| 374 |
Yong-fang Ding, Zhen-hui Wu, Ying-jie Wei, Luan Shu, Yun-ru Peng. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine. Journal of Cancer Research and Clinical Oncology 2017; 143(5) doi: 10.1007/s00432-017-2364-z
|
| 375 |
Fabián Segovia-Miranda, Hernán Morales-Navarrete, Michael Kücken, Vincent Moser, Sarah Seifert, Urska Repnik, Fabian Rost, Mario Brosch, Alexander Hendricks, Sebastian Hinz, Christoph Röcken, Dieter Lütjohann, Yannis Kalaidzidis, Clemens Schafmayer, Lutz Brusch, Jochen Hampe, Marino Zerial. Three-dimensional spatially resolved geometrical and functional models of human liver tissue reveal new aspects of NAFLD progression. Nature Medicine 2019; 25(12) doi: 10.1038/s41591-019-0660-7
|
| 376 |
Shian Yu, Xinhua Jiang, Long Peng, Xianwen Zeng, Suqi Wen, Hui Xiong, Sumei Guo, Fufeng Huang, Hanwen Liu, Qiulan Luo. Integrated bioinformatics decoding of the MASLD ceRNA network reveals novel therapeutic targets. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01890-x
|
| 377 |
Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, Regina Lo, Kihan Yap, Haeryoung Kim. Non-alcoholic fatty liver disease: the pathologist’s perspective. Clinical and Molecular Hepatology 2023; 29(Suppl) doi: 10.3350/cmh.2022.0329
|
| 378 |
Darrell Pilling, Nehemiah Cox, Megan A. Thomson, Tejas R. Karhadkar, Richard H. Gomer. Serum Amyloid P and a Dendritic Cell–Specific Intercellular Adhesion Molecule-3–Grabbing Nonintegrin Ligand Inhibit High-Fat Diet–Induced Adipose Tissue and Liver Inflammation and Steatosis in Mice. The American Journal of Pathology 2019; 189(12) doi: 10.1016/j.ajpath.2019.08.005
|
| 379 |
Diana Zamosteanu, Nina Filip, Ludmila Lozneanu, Simona Eliza Giusca, Oana Viola Badulescu, Mihaela Pertea, Alexandru Filip, Carmen Ungureanu, Eugenia Morosan, Elena Cojocaru. Amino Acids—Potential Biomarkers of Histological Features for MASLD in Pediatric Obesity. International Journal of Molecular Sciences 2026; 27(8) doi: 10.3390/ijms27083596
|
| 380 |
Kwang Baek Kim, Gwang Ha Kim, Doo Heon Song, Hyun Jun Park, Chang Won Kim. Automatic segmentation of liver/kidney area with double-layered fuzzy C-means and the utility of hepatorenal index for fatty liver severity classification. Journal of Intelligent & Fuzzy Systems: Applications in Engineering and Technology 2020; 39(1) doi: 10.3233/JIFS-191850
|
| 381 |
Yuan Yuan, Hisao Naito, Tamie Nakajima. Cholesterol - Good, Bad and the Heart. 2018; doi: 10.5772/intechopen.76199
|
| 382 |
Mark G. Swain, Billie Pettersson, Oren Meyers, Meredith Venerus, Jan Oscarsson. A qualitative patient interview study to understand the experience of patients with nonalcoholic steatohepatitis. Hepatology Communications 2023; 7(3) doi: 10.1097/HC9.0000000000000036
|
| 383 |
Manca Povsic, Louisa Oliver, Neha Raju Jiandani, Richard Perry, Juliana Bottomley. A structured literature review of interventions used in the management of nonalcoholic steatohepatitis (NASH). Pharmacology Research & Perspectives 2019; 7(3) doi: 10.1002/prp2.485
|
| 384 |
Ahsan Ali Siddiqui, Stein K. F. Stoter, David Néron, Dominik Schillinger. Hybrid reduced-order models for real-time simulation of blood perfusion in parameterized lobular structures. Computational Mechanics 2026; 77(3) doi: 10.1007/s00466-025-02681-7
|
| 385 |
Shun Takano, Koudai Kani, Kaichi Kasai, Naoya Igarashi, Miyuna Kato, Kana Goto, Yudai Matsuura, Mayuko Ichimura‐Shimizu, Shiro Watanabe, Koichi Tsuneyama, Yukihiro Furusawa, Yoshinori Nagai. Antibiotic effects on gut microbiota modulate diet‐induced metabolic dysfunction‐associated steatohepatitis development in C57BL/6 mice. Genes to Cells 2024; 29(8) doi: 10.1111/gtc.13134
|
| 386 |
Qianqian Jiang, Qi Li, Beibei Liu, Guixin Li, Gabriel Riedemann, Haristi Gaitantzi, Katja Breitkopf-Heinlein, Ajuan Zeng, Huiguo Ding, Keshu Xu. BMP9 promotes methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in non-obese mice by enhancing NF-κB dependent macrophage polarization. International Immunopharmacology 2021; 96 doi: 10.1016/j.intimp.2021.107591
|
| 387 |
Charles Drummer, Fatma Saaoud, Nirag C. Jhala, Ramon Cueto, Yu Sun, Keman Xu, Ying Shao, Yifan Lu, Huimin Shen, Ling Yang, Yan Zhou, Jun Yu, Sheng Wu, Nathaniel W. Snyder, Wenhui Hu, Jia ‘Joe’ Zhuo, Yinghui Zhong, Xiaohua Jiang, Hong Wang, Xiaofeng Yang. Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1113883
|
| 388 |
Laura Comi, Claudia Giglione, Fationa Tolaj Klinaku, Lorenzo Da Dalt, Hammad Ullah, Maria Daglia, Paolo Magni. Evaluation of Metabolic Dysfunction-Associated Fatty Liver Disease-Related Pathogenic Mechanisms in Human Steatotic Liver Cell-Based Model: Beneficial Effects of Prunus domestica L. subsp. syriaca Extract. Nutrients 2025; 17(7) doi: 10.3390/nu17071249
|
| 389 |
Michael L. Attanasi, Mathew J. Gregoski, Don C. Rockey. Racial Differences in Liver Fibrosis Burden. Digestive Diseases and Sciences 2025; 70(6) doi: 10.1007/s10620-025-08936-w
|
| 390 |
Janjira Prasomthong, Nanteetip Limpeanchob, Supawadee Daodee, Pennapa Chonpathompikunlert, Sakara Tunsophon. Hibiscus sabdariffa extract improves hepatic steatosis, partially through IRS-1/Akt and Nrf2 signaling pathways in rats fed a high fat diet. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-11027-9
|
| 391 |
Tasur Kumar Seen, Muntazir Sayed, Muhammad Bilal, Jonathan Vincent Reyes, Priyanka Bhandari, Vennis Lourdusamy, Ahmed Al-khazraji, Umer Syed, Yasar Sattar, Raghav Bansal. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis. World Journal of Gastroenterology 2021; 27(23): 3238-3248 doi: 10.3748/wjg.v27.i23.3238
|